IN FORCE Advance Authorisation

DGFT Minutes

Reliability

In force — no superseding record on file.

Document text

Office of Directorate General of Foreign Trade New Delhi -0

-----------------------------------------------------------------------------Para 4.7 Decision

Minutes of the Norms Committee – 3 Meeting No. 1/82-ALC4/2020 dated 17.04.2020 (actually held on 06.05.2020) for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30, held under the Chairmanship of Shri Satyan Sharda, Addl. DGFT in Room No.11, Udyog Bhawan, New Delhi.

Following members were present in the Meeting:

(i) Shri Nirmal Kumar, Dy. Director General of Foreign Trade (ii) Shri Ajay Kumar, Assistant Director (iii) Consultant, Technical Expert Pharmaceuticals (iv) Consultant, Technical Expert Chemicals

The committee went through the minutes of earlier meeting No. 14/82-ALC4/2019 dated 06.03.2020 dated 06.03.2020 (actually held on 19.03.2020)

ONLINE CASES

1	Case No.:969/15/82-<br>ALC4/2018	Party Name:SOMU<br>SOLVENTS PVT. LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/02426/AM19/	RLA File<br>:07/24/040/00175/AM16/	Lic.No/Date:0710108673<br>02.09.2015	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

Decision: The Committee noted that the 4.07 application of subject Advance Authorization is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

2	Case No.:405/15/82-<br>ALC4/2018	Party Name:SHIVA<br>PHARMACHEM LTD,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/01862/AM19/	RLA File<br>:34/24/040/00139/AM16/	Lic.No/Date:3410041522<br>16.09.2015	Defer Date:
	Decision:Deferred for comments of TE.

Case No.:259/15/82-	Party Name:CADILA	Meet No/Date:1/82-	Status:
ALC4/2018	PHARMACEUTICALS LTD.	ALC4/2020	Withdrawn
		17.04.2020
HQ File	RLA File	Lic.No/Date:0810136251
:01/82/050/01716/AM19/	:08/24/040/00222/AM16/	12.10.2015

||ALC4/2018||PHARMACEUTICALS LTD.||ALC4/2020||Withdrawn| ||||||17.04.2020||| ||HQ File||RLA File||Lic.No/Date:0810136251||| ||:01/82/050/01716/AM19/||:08/24/040/00222/AM16/||12.10.2015|||

3 Decision: The firm vide its e-mail dated 24.02.2020 has enclosed a copy of Redemption Letter dated 13.05.2017 vide which Office of Addl. DGFT, Ahmedabad has issued EODC and closed the subject advance authorization.

In view of above, the Committee decided to withdraw the case.

Case No.:322/15/82-	Party Name:HESTER	Meet No/Date:1/82-	Status:
ALC4/2018	BIOSCIENCES LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0810136418	Defer Date:
:01/82/050/01779/AM19/	:08/24/040/00270/AM16/	02.11.2015

Decision: The Committee considered the case as per online agenda in the presence of technical experts 4 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Hence, it was decided to issue Final Reminder to firm with the request to furnish a copy of 4.07 application of the subject advance authorization immediately to this Directorate as per Policy Circular No. 23/2015-20, dated 15.05.2019, failing which its case will be rejected.

ish a copy of 4.07 application of the subject advance authorization immediately to this Directorate as per Policy Circular No. 23/2015-20, dated 15.05.2019, failing which its case will be rejected.

Case No.:1030/15/82-	Party Name:SWATI	Meet No/Date:1/82-	Status:
ALC4/2018	MENTHOL & ALLIED	ALC4/2020	Deferred
	CHEMICALS LTD.,	17.04.2020
HQ File	RLA File	Lic.No/Date:2910025235	Defer Date:
:01/82/050/02487/AM19/	:29/21/040/00029/AM16/	21.12.2015

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 5 Meeting No. 7/82-ALC4/2019 dated 06.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020.

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage.

(ii) Central Excise or GST Certificate.

The requisite reply is still awaited from the firm.

In view of above, the Committee decided to defer the case.

Case No.:260/15/82-	Party Name:VINNY	Meet No/Date:1/82-	Status:
ALC4/2018	HEALTHCARE PRIVATE	ALC4/2020	Deferred
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0810137198	Defer Date:
:01/82/050/01717/AM19/	:08/24/040/00386/AM16/	12.02.2016

18**||HEALTHCARE PRIVATE||ALC4/2020||Deferred| |||LIMITED||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0810137198||Defer Date:| |:01/82/050/01717/AM19/||:08/24/040/00386/AM16/||12.02.2016|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts 6 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

	Case No.:996/15/82-	Party Name:RECKITT	Meet No/Date:1/82-	Status:
	ALC4/2018	BENCKISER ( INDIA) LTD	ALC4/2020	Withdrawn
			17.04.2020
	HQ File	RLA File	Lic.No/Date:0710109433
7	:01/82/050/02453/AM19/	:07/24/040/00374/AM16/	23.02.2016
	Decision:The firm vide e-mail dated 26.02.2020 has informed that they have surrendered the subject
	Advance Authorization.
	In view of above,the Committee decided towithdrawthe case

irm vide e-mail dated 26.02.2020 has informed that they have surrendered the subject||||||| |||Advance Authorization.||||||| |||In view of above,the Committee decided towithdrawthe case|||||||

	Case No.:221/15/82-<br>Party Name:GOPINATH<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>CHEM-TECH LTD.,<br>ALC4/2020		Deferred
	17.04.2020
8	HQ File<br>:01/82/050/01678/AM19/<br>RLA File<br>:08/24/040/00469/AM16/<br>Lic.No/Date:0810137649<br>11.04.2016		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

Case No.:274/15/82-	Party Name:SHILPA	Meet No/Date:1/82-	Status:
ALC4/2018	MEDICARE LTD.,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710109729	Defer Date:
:01/82/050/01731/AM19/	:07/24/040/00034/AM17/	27.04.2016

|ALC4/2018||MEDICARE LTD.,||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0710109729||Defer Date:| |:01/82/050/01731/AM19/||:07/24/040/00034/AM17/||27.04.2016|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and 9 it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019. Hence, it was decided to issue Final Reminder to firm with the request to furnish a copy of 4.07 application of the subject advance authorization immediately to this Directorate as per Policy Circular No. 23/2015-20, dated 15.05.2019, failing which its case will be rejected.

Case No.:222/15/82-	Party Name:ADCOCK	Meet No/Date:1/82-	Status:
ALC4/2018	INGRAM LTD,	ALC4/2020	Approved
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710109746
:01/82/050/01679/AM19/	:07/24/040/00015/AM17/	02.05.2016

-|---|---|---| |ALC4/2018||INGRAM LTD,||ALC4/2020||Approved| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0710109746||| |:01/82/050/01679/AM19/||:07/24/040/00015/AM17/||02.05.2016|||

		ALC4/2018<br>INGRAM LTD,<br>ALC4/2020<br>17.04.2020<br>Approved<br>HQ File<br>:01/82/050/01679/AM19/<br>RLA File<br>:07/24/040/00015/AM17/<br>Lic.No/Date:0710109746<br>02.05.2016	ALC4/2018<br>INGRAM LTD,<br>ALC4/2020<br>17.04.2020<br>Approved<br>HQ File<br>:01/82/050/01679/AM19/<br>RLA File<br>:07/24/040/00015/AM17/<br>Lic.No/Date:0710109746<br>02.05.2016	ALC4/2018<br>INGRAM LTD,<br>ALC4/2020<br>17.04.2020<br>Approved<br>HQ File<br>:01/82/050/01679/AM19/<br>RLA File<br>:07/24/040/00015/AM17/<br>Lic.No/Date:0710109746<br>02.05.2016	ALC4/2018<br>INGRAM LTD,<br>ALC4/2020<br>17.04.2020<br>Approved<br>HQ File<br>:01/82/050/01679/AM19/<br>RLA File<br>:07/24/040/00015/AM17/<br>Lic.No/Date:0710109746<br>02.05.2016	ALC4/2018<br>INGRAM LTD,<br>ALC4/2020<br>17.04.2020<br>Approved<br>HQ File<br>:01/82/050/01679/AM19/<br>RLA File<br>:07/24/040/00015/AM17/<br>Lic.No/Date:0710109746<br>02.05.2016	ALC4/2018<br>INGRAM LTD,<br>ALC4/2020<br>17.04.2020<br>Approved<br>HQ File<br>:01/82/050/01679/AM19/<br>RLA File<br>:07/24/040/00015/AM17/<br>Lic.No/Date:0710109746<br>02.05.2016
		Decision:The Committee considered case as per agenda in the presence of the technical experts and it
		was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied

nsidered case as per agenda in the presence of the technical experts and it|||||| |||was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied|||||| |||by firm whichever is lower:|||||| |||Export Product|Qty.|Sl.|Import items|Qty.|| |||||No.|||| |||ACURATE TABS -|25347.000 kg|1|PARACETAMOL|22950.000 kg|| |10||Paracetamol 450mg+Doxylamine|||GRANULES DC 83S (KRISOPAP - 83S)||| |||Succinate 5mg+Caffeine||2|DOXYLAMINE|255.000 kg|| |||30mg|||SUCCINATE USP /Ph. Eur||| |||+Codeine Phosphate|||Grade||| |||10mg+Colour Quinoline||3|CAFFEINE ANHYDROUS|1530.000 kg|| |||Yellow 2Mg Tablets (Para|||BP2010/USP/EP/PH.EUR/BP||| |||-22500.000+Doxy- 250.000+Caffeine-||4|CODEINE PHOSPHATE BP/USP/EP/PH.EUR|510.000 kg|| |||1500.000+Codeine- 500.000+Colour-||5|COLOUR QUINOLINE YELLOW CI 47005|102.000 kg|| |||100.000Kgs)(No. of Tablets 50000000)|||(SPECTRACOL)||| |||RA concerned maytake further|necessaryaction|asper above decision of NC.||||

Decision: The Committee considered case as per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:

s per agenda in the presence of the technical experts and it was decided to ratify the ad-hoc input output norms under para 4.7 of HBP as per details below or as applied by firm whichever is lower:

Case No.:286/15/82-	Party Name:MOREPEN	Party Name:MOREPEN	Meet No/Date:1/82-	Status:
ALC4/2018	LABORATORIES LTD.,		ALC4/2020	Approved
			17.04.2020
HQ File	RLA File		Lic.No/Date:0510398453
:01/82/050/01743/AM19/	:05/24/040/00060/AM17/		11.05.2016
Decision:The Committee	considered the cases as per agenda and in the light of earlier			decision taken in
meeting	no.	18/82-ALC4/2014		dated
18.02.2015, it was decided to	ratify norms under Para 4.7 of HBP v1 as per details given below or as applied
by the firm, whichever is less:
Export product<br>SITAGLIPTIN<br>PHOSPHATE	Qty.<br>Sl. No.<br>1 k<br>1	Import items<br>( R )-3-((tert-butoxycarbonyl)amino)-<br>4-(2,4,5-trifluorophenyl)butanoic acid		Qty.<br>1.00 kg/kg
MONOHYDRATE		(SG04)
	2	3-(trifluoromethyl)-5,6,7,8-tetrahydro-<br>[1,2,4]triazolo[4,3-a]pyrazine		0.80 kg/kg
		hydrochloride
	3	N-Hydroxybenzotriazole(HOBT)		0.50 kg/kg
	4	Methanol		3.65 lit/kg
	5	Isopropyl alcohol		6.10 lit/kg
	6	Methylene Dichloride		15.25 lt/kg
RA concerned maytake further necessaryaction asper above decision of NC.

g|| |||4|Methanol|||3.65 lit/kg|| |||5|Isopropyl alcohol|||6.10 lit/kg|| |||6|Methylene Dichloride|||15.25 lt/kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Case No.:286/15/82-	Party Name:MOREPEN	Party Name:MOREPEN	Meet No/Date:1/82-	Status:
ALC4/2018	LABORATORIES LTD.,		ALC4/2020	Approved
			17.04.2020
HQ File	RLA File		Lic.No/Date:0510398453
:01/82/050/01743/AM19/	:05/24/040/00060/AM17/		11.05.2016
Decision:The Committee	considered the cases as per agenda and in the light of earlier			decision taken in
meeting	no.	18/82-ALC4/2014		dated
18.02.2015, it was decided to	ratify norms under Para 4.7 of HBP v1 as per details given below or as applied
by the firm, whichever is less:
Export product<br>SITAGLIPTIN<br>PHOSPHATE	Qty.<br>Sl. No.<br>1 k<br>1	Import items<br>( R )-3-((tert-butoxycarbonyl)amino)-<br>4-(2,4,5-trifluorophenyl)butanoic acid		Qty.<br>1.00 kg/kg
MONOHYDRATE		(SG04)
	2	3-(trifluoromethyl)-5,6,7,8-tetrahydro-<br>[1,2,4]triazolo[4,3-a]pyrazine		0.80 kg/kg
		hydrochloride
	3	N-Hydroxybenzotriazole(HOBT)		0.50 kg/kg
	4	Methanol		3.65 lit/kg
	5	Isopropyl alcohol		6.10 lit/kg
	6	Methylene Dichloride		15.25 lt/kg
RA concerned maytake further necessaryaction asper above decision of NC.

|||4|Methanol|||3.65 lit/kg|| |||5|Isopropyl alcohol|||6.10 lit/kg|| |||6|Methylene Dichloride|||15.25 lt/kg|| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Case No.:230/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710109922	Defer Date:
:01/82/050/01687/AM19/	:07/24/040/00083/AM17/	08.06.2016

Decision: The Committee considered the case as per online agenda in the presence of technical experts 12 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:231/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710109921	Defer Date:
:01/82/050/01688/AM19/	:07/24/040/00082/AM17/	08.06.2016

-|---| |ALC4/2018||LIMITED,||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0710109921||Defer Date:| |:01/82/050/01688/AM19/||:07/24/040/00082/AM17/||08.06.2016|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts 13 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:501/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710109926	Defer Date:
:01/82/050/01958/AM19/	:07/24/040/00081/AM17/	09.06.2016

Decision: The Committee considered the case as per online agenda in the presence of technical experts 14 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:234/15/82-	Party Name:R L FINE CHEM	Meet No/Date:1/82-	Status:
ALC4/2018		ALC4/2020	Approved
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710109991
:01/82/050/01691/AM19/	:07/24/040/00057/AM17/	23.06.2016

Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 3/82-ALC4/2018 dated 15 05.06.2018, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:

the firm, whichever is less:
Export Product	Qty.	Sl. No.	Import items	Qty.
TRIMIPRAMINE<br>MESYLATE<br>IHT	1 kg	1	1 BROMO 3 CHLORO 2<br>METHYL PROPANE	0.53 kg
		2	IMINODIBENZYL	0.72 kg

RA concerned may take further necessary action as per above decision of NC.

ty.| |TRIMIPRAMINE MESYLATE IHT|1 kg|1|1 BROMO 3 CHLORO 2 METHYL PROPANE|0.53 kg| |||2|IMINODIBENZYL|0.72 kg|

RA concerned may take further necessary action as per above decision of NC.

16	Case No.:179/6/82-ALC4/2019	Party Name:CIPLA LIMITED.<br>RLA File<br>:03/94/040/00257/AM17/	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Withdrawn
	<br>HQ File<br>:01/82/050/00405/AM20/		Lic.No/Date:0310805901<br>04.07.2016
	Decision:The firm vide e-mail dated 29.01.2020 has informed that they have surrendered the subject<br>Advance Authorization.<br>In view of above,the Committee decided towithdrawthe case.

Case No.:646/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710110596	Defer Date:
:01/82/050/02103/AM19/	:07/24/040/00251/AM17/	28.10.2016

Decision: The Committee considered the case as per online agenda in the presence of technical experts 17 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:680/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710110805	Defer Date:
:01/82/050/02137/AM19/	:07/24/040/00282/AM17/	16.12.2016

Decision: The Committee considered the case as per online agenda in the presence of technical experts 18 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

ish a copy of 4.07 application of the subject advance authorization immediately to this Directorate as per Policy Circular No. 23/2015-20, dated 15.05.2019, failing which its case will be rejected.

	Case No.:265/15/82-	Party Name:ATUL LIMITED,	Meet No/Date:1/82-	Status:
	ALC4/2018		ALC4/2020	Deferred
			17.04.2020
19	HQ File	RLA File	Lic.No/Date:0810139395	Defer Date:
	:01/82/050/01722/AM19/	:08/24/040/00374/AM17/	28.12.2016
	Decision:Deferred for comments of TE.

Case No.:992/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710111032	Defer Date:
:01/82/050/02449/AM19/	:07/24/040/00353/AM17/	27.01.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts 20 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

ish a copy of 4.07 application of the subject advance authorization immediately to this Directorate as per Policy Circular No. 23/2015-20, dated 15.05.2019, failing which its case will be rejected.

Case No.:995/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710111117	Defer Date:
:01/82/050/02452/AM19/	:07/24/040/00362/AM17/	10.02.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts 21 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:1002/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710111160	Defer Date:
:01/82/050/02459/AM19/	:07/24/040/00365/AM17/	21.02.2017

-|---| |ALC4/2018||LIMITED,||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0710111160||Defer Date:| |:01/82/050/02459/AM19/||:07/24/040/00365/AM17/||21.02.2017|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts 22 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

23	Case No.:276/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD.,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:0510401758<br>22.02.2017	Status:<br>Deferred<br>Defer Date:
	<br>HQ File<br>:01/82/050/01733/AM19/	RLA File<br>:05/23/040/00561/AM17/
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

t available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.||||

Case No.:382/4/82-ALC4/2017	Party Name:ELPPE	Meet No/Date:1/82-	Status:
	CHEMICALS PRIVATE	ALC4/2020	Deferred
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0310812684	Defer Date:
:01/82/050/00390/AM18/	:03/94/040/00036/AM18/	24.04.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 24 Meeting No. 14/82-ALC4/2019 dated 06.03.2020 , followed by Reminder on 11.06.2020 :

(i) Justification for low yield, that is 72% and 56% with supporting data. (ii) Production – Consumption data for the last two years duly certified by GST authority.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

he last two years duly certified by GST authority.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:294/15/82-	Party Name:SUPREET	Meet No/Date:1/82-	Status:
ALC4/2018	CHEMICALS PVT.LTD.	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:5210042249	Defer Date:
:01/82/050/01751/AM19/	:52/24/040/00006/AM18/	02.05.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts 25 and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Recovery of By-Product i.e. Para Amino Phenol and its commercial value.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:282/15/82-	Party Name:MSN	Meet No/Date:1/82-	Status:
ALC4/2018	PHARMACHEM PRIVATE	ALC4/2020	Approved
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0910065021
:01/82/050/01739/AM19/	:09/24/040/00067/AM18/	11.05.2017

|ALC4/2018||PHARMACHEM PRIVATE||ALC4/2020||Approved| |||LIMITED||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0910065021||| |:01/82/050/01739/AM19/||:09/24/040/00067/AM18/||11.05.2017|||

Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 4/82-ALC4/2018 dated 19.06.2018, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: 26

applied by the firm, whichever is less:
Export Product	Qty.	Sl. No	Import Product	Qty.
Oseltamivir Phosphate	1 kg	1.	Shikimic acid	1.66 kg
		2.	2,2 -DimethoxyPropane	1.58 kg
		3	3 - Pentanone	5.57 kg
		4	Triethylsilane	0.90 kg
		5	Triethylamine	1.00 kg
		6	Trifluoromethane Sulfonic acid	0.100 kg

RA concerned may take further necessary action as per above decision of NC.

27	Case No.:289/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:0810140311<br>18.05.2017	Status:<br>Deferred
	HQ File<br>:01/82/050/01746/AM19/	RLA File<br>:08/24/040/00043/AM18/		Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 25.02.2020 has furnished its reply. Deferred for comments of<br>TE.

the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 25.02.2020 has furnished its reply. Deferred for comments of TE.||||

Case No.:290/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710111636	Defer Date:
:01/82/050/01747/AM19/	:07/24/040/00052/AM18/	23.05.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts 28 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:291/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710111650	Defer Date:
:01/82/050/01748/AM19/	:07/24/040/00056/AM18/	24.05.2017

-|---| |ALC4/2018||LIMITED,||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0710111650||Defer Date:| |:01/82/050/01748/AM19/||:07/24/040/00056/AM18/||24.05.2017|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts 29 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

Case No.:525/4/82-ALC4/2017	Party Name:CIPLA LIMITED.	Meet No/Date:1/82-	Status:
		ALC4/2020	Approved
		17.04.2020
HQ File	RLA File	Lic.No/Date:0310813980
:01/82/050/00533/AM18/	:03/94/040/00211/AM18/	14.06.2017

atus:**| |---|---|---|---|---|---|---| |||||ALC4/2020||Approved| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0310813980||| |:01/82/050/00533/AM18/||:03/94/040/00211/AM18/||14.06.2017|||

	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in
	meeting		no.			3/82-ALC4/2018
	dated 05.06.2018, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as
	applied by the firm, whichever is less:
30		Export product	Qty.	Sl.<br>No.	Import items	Qty.

t was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as||||||| |||applied by the firm, whichever is less:||||||| |30|||Export product|Qty.|Sl. No.|Import items|Qty. allowed mg/tablet|| ||||Tenofovir Disoproxil Fumarate|1 Number|1|Efavirenz|612.0|| ||||300mg+ Lamivudine 300mg +||2|Lamivudine|306.0|| ||||Efavirenz 600mg Tablets||3|9-[2-(Phosphonyl Methoxy)|235.3|| ||||Each Tablet contain Efavirenz|||Propyl] Adenine (PMPA)||| ||||600mg + Tenofovir Disoproxil||4|Chloromethyl Isopropyl|413.92|| ||||Fumarate 300mg + Lamivudine 300mg Tablets||5 6|Carbonate N-Methyl 2-Pyrrolidone Methylene Dichloride|455.27 2050.20|| |||RA concerned maytake further necessaryaction asper above decision of NC.|||||||

Case No.:109/12/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065247	Defer Date:
:01/82/050/01064/AM18/	:09/24/040/00181/AM18/	06.07.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following informationas asked for by NC-3 in its 31 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

2-ALC4/2019 dated 17.01.2020** , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

32	Case No.:309/15/82-<br>ALC4/2018	Party Name:DISCOVERY<br>INTERMEDIATES PVT LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01766/AM19/	RLA File<br>:09/24/040/00157/AM18/	Lic.No/Date:0910065252<br>07.07.2017	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>noted that the firm vide its e-mail dated 20.02.2020 has furnished its reply. Deferred for comments of TE.

33	Case No.:311/15/82-<br>ALC4/2018	Party Name:ASSOCIATED<br>DYESTUFF PVT. LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01768/AM19/	RLA File<br>:08/24/040/00123/AM18/	Lic.No/Date:0810140725<br>26.07.2017	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019

ot available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019||||

34	Case No.:297/12/82-<br>ALC4/2018	Party Name:GLOBAL<br>CALCIUM PRIVATE<br>LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00924/AM19/	RLA File<br>:07/24/040/00129/AM18/	Lic.No/Date:0710111984<br>08.08.2017	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019

not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019

Case No.:116/12/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065373	Defer Date:
:01/82/050/01071/AM18/	:09/24/040/00234/AM18/	23.08.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 35 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:134/12/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065372	Defer Date:
:01/82/050/01089/AM18/	:09/24/040/00233/AM18/	23.08.2017

--|---| |ALC4/2017||LIMITED||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0910065372||Defer Date:| |:01/82/050/01089/AM18/||:09/24/040/00233/AM18/||23.08.2017|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 36 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:131/12/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065396	Defer Date:
:01/82/050/01086/AM18/	:09/24/040/00238/AM18/	28.08.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting 37 No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

2-ALC4/2019 dated 17.01.2020** , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:132/12/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065398	Defer Date:
:01/82/050/01087/AM18/	:09/24/040/00235/AM18/	28.08.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting 38 No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:141/12/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2017	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065397	Defer Date:
:01/82/050/01096/AM18/	:09/24/040/00236/AM18/	28.08.2017

--|---| |ALC4/2017||LIMITED||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0910065397||Defer Date:| |:01/82/050/01096/AM18/||:09/24/040/00236/AM18/||28.08.2017|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 39 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.


40	Case No.:321/15/82-<br>ALC4/2018	Party Name:AASHA<br>BIOCHEM	Meet No/Date:1/82-<br>ALC4/2020<br>17042020	Status:<br>Deferred
			..
	HQ File<br>:01/82/050/01778/AM19/	RLA File<br>10/24/040/00018/AM18/	Lic.No/Date:1010059805<br>31082017	Defer Date:
		:	..
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>noted that the firm vide its e-mail dated 25022020 has furnished its relDeferred for comments of TE
	..py. .

the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 25022020 has furnished its relDeferred for comments of TE|||| ||..py. .||||

41	Case No.:198/4/82-<br>ALC4/2018	Party Name:SAPTAGIR<br>CAMPHOR LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/00198/AM19/	RLA File<br>:09/24/040/00293/AM18/	Lic.No/Date:0910065468<br>15.09.2017	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 24.02.2020 has furnished its reply. Deferred for comments of<br>TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 24.02.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:327/15/82-<br>Party Name:JODAS EXPOIM<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>PVT.LTD.,<br>ALC4/2020		Deferred
	17.04.2020
42	HQ File<br>:01/82/050/01784/AM19/<br>RLA File<br>:05/23/040/00268/AM18/<br>Lic.No/Date:0510404290<br>13.10.2017		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

|||available. Hence, it was decided to call for a copy of 4.07 application of the subject advance|authorization|| |||directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.|||

	Case No.:328/15/82-<br>Party Name:JODAS EXPOIM<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>PVT.LTD.,<br>ALC4/2020		Deferred
	17.04.2020
43	HQ File<br>:01/82/050/01785/AM19/<br>RLA File<br>:05/23/040/00266/AM18/<br>Lic.No/Date:0510404285<br>13.10.2017		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:329/15/82-<br>Party Name:JODAS EXPOIM<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>PVT.LTD.,<br>ALC4/2020		Deferred
	17.04.2020
44	HQ File<br>:01/82/050/01786/AM19/<br>RLA File<br>:05/23/040/00267/AM18/<br>Lic.No/Date:0510404287<br>13.10.2017		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:550/15/82-	Party Name:TADIMETY	Meet No/Date:1/82-	Status:
	ALC4/2018	AROMATICS PVT. LTD	ALC4/2020	Deferred
			17.04.2020
45	HQ File<br>:01/82/050/02007/AM19/	RLA File<br>:07/24/040/00202/AM18/	Lic.No/Date:0710112366<br>08.11.2017	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it
	was noted that the firm vide its	e-mail dated 21.03.2020 has furnished its reply. Deferred for comments
	of TE.

Case No.:236/4/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065688	Defer Date:
:01/82/050/00236/AM19/	:09/24/040/00403/AM18/	24.11.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 46 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

2-ALC4/2019 dated 17.01.2020** , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:243/4/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065687	Defer Date:
:01/82/050/00243/AM19/	:09/24/040/00404/AM18/	24.11.2017

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 47 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

ntary evidence. (ii) Complete set of 4.07 application.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

	Case No.:1021/15/82-<br>Party Name:ANLON<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>HEALTHCARE<br>ALC4/2020		Deferred
	PRIVATELIMITED<br>17.04.2020
48	HQ File<br>:01/82/050/02478/AM19/<br>RLA File<br>:24/24/040/00039/AM18/<br>Lic.No/Date:2410042334<br>12.01.2018		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

49	Case No.:12/4/82-ALC4/2018	Party Name:MELOG<br>SPECIALITY CHEMICALS<br>PVT. LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/00012/AM19/	RLA File<br>:03/95/040/00810/AM18/	Lic.No/Date:0310818490<br>15.01.2018	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 07.11.2019 has furnished its reply. Deferred for comments of<br>TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 07.11.2019 has furnished its reply. Deferred for comments of TE.

Case No.:165/10/82-	Party Name:AURORE LIFE	Meet No/Date:1/82-	Status:
ALC4/2018	SCIENCES PRIVATE	ALC4/2020	Deferred
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0910065915	Defer Date:
:01/82/050/00452/AM19/	:09/24/040/00438/AM18/	20.01.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts 50 and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Percentage of yield on molar basis for each step.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:187/10/82-	Party Name:NISARG	Meet No/Date:1/82-	Status:
ALC4/2018	BIOSCIENCES PVT LTD	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065945	Defer Date:
:01/82/050/00474/AM19/	:09/24/040/00497/AM18/	31.01.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting 51 No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020.

(i) Exact chemical name of the export product.

52	<br>Case No.:132/10/82-<br>ALC4/2018	Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00419/AM19/	RLA File<br>:09/24/040/00516/AM18/	Lic.No/Date:0910065954<br>01.02.2018	Defer Date:
	Decision:Deferred for comments of TE.

	Case No.:131/10/82-	Case No.:131/10/82-	Party Name:SUVEN LIFE	Party Name:SUVEN LIFE	Party Name:SUVEN LIFE	Party Name:SUVEN LIFE	Party Name:SUVEN LIFE	Meet No/Date:1/82-	Meet No/Date:1/82-	Status:
53	<br>ALC4/2018		<br>SCIENCES LIMITED					ALC4/2020<br>17.04.2020		<br>Approved
	HQ File<br>:01/82/050/00418/AM19/		RLA File					Lic.No/Date:091006	5961
			:09/24/040/00561/AM18/					02.02.2018
	Decision:The Committee considered<br>meeting<br>no.<br>31.01.2020, it was decided to ratify norms<br>by the firm, whichever is less:	onsidered		the cases as per age			nda and in the light of earl		ier decision taken in
				<br>13/82-ALC4/2019<br>dated<br>under Para 4.7 of HBP v1 as per details given below or as applied

	Export product			Qty.	Sl.<br>N	Import items				Qty.
					o.
	Cis MONOQUATERNARY<br>BESYLATE SALT		ACID	1 kg	1	HOM		OVERATRYLAMINE		2.10 kg
					2	HOM		OVERATRIC ACID		2.27 kg
					3	RuCI[		(S,S)-Tsdpen(p-cymene)]		0.010 kg
					4	ACET		<br>ONITRILE		<br>3.10 kg
					5	TETR		AHYDROFURAN		3.57 kg

kg|1|HOM||OVERATRYLAMINE||2.10 kg| ||||||2|HOM||OVERATRIC ACID||2.27 kg| ||||||3|RuCI[||(S,S)-Tsdpen(p-cymene)]||0.010 kg| ||||||4|ACET|| ONITRILE|| 3.10 kg| ||||||5|TETR||AHYDROFURAN||3.57 kg| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||||| ||||||||||||

Case No.:135/10/82-	Party Name:NISARG	Meet No/Date:1/82-	Status:
ALC4/2018	BIOSCIENCES PVT LTD	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910065963	Defer Date:
:01/82/050/00422/AM19/	:09/24/040/00498/AM18/	02.02.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 54 Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020.

(i) Percentage yield on molar basis at every stage. (ii) Exact chemical name of the export product.

	Case No.:140/10/82-	Party Name:ORTIN	Meet No/Date:1/82-	Status:
	ALC4/2018	LABORATORIES LTD	ALC4/2020	Deferred
			17.04.2020
55	HQ File	RLA File	Lic.No/Date:0910065968	Defer Date:
	:01/82/050/00427/AM19/	:09/24/040/00527/AM18/	06.02.2018
	Decision:Deferred for comments of TE.

17.04.2020||| |55||HQ File||RLA File||Lic.No/Date:0910065968||Defer Date:| |||:01/82/050/00427/AM19/||:09/24/040/00527/AM18/||06.02.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:142/4/82-ALC4/2018	Party Name:HERBOCHEM	Meet No/Date:1/82-			Status:
		INDUSTRIES	ALC4/2020			Deferred
			17.04.2020
56	HQ File<br>:01/82/050/00142/AM19/	RLA File<br>:06/24/040/00047/AM18/	Lic.No/Date:0610038810<br>07.02.2018			Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical			experts and it
	was noted that the firm vide its e-mail dated 25.02.2020 has furnished its reply. Deferred for				comments of
	TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 25.02.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:166/10/82-	Party Name:ORTIN	Meet No/Date:1/82-	Status:
	ALC4/2018	LABORATORIES LTD	ALC4/2020	Deferred
			17.04.2020
57	HQ File	RLA File	Lic.No/Date:0910065973	Defer Date:
	:01/82/050/00453/AM19/	:09/24/040/00528/AM18/	07.02.2018
	Decision:Deferred for comments of TE.

|||||17.04.2020||| |57||HQ File||RLA File||Lic.No/Date:0910065973||Defer Date:| |||:01/82/050/00453/AM19/||:09/24/040/00528/AM18/||07.02.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:819/15/82-<br>Party Name:DHANUKA	Meet No/Date:1/82-	Status:
	ALC4/2018<br>LABORATORIES LTD	ALC4/2020	Deferred
		17.04.2020
58	HQ File<br>:01/82/050/02276/AM19/<br>RLA File<br>:05/23/040/00440/AM18/	Lic.No/Date:0510405609<br>09.02.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:1009/15/82-		Party Name:TADIMETY	Meet No/Date:1/82-			Status:
	ALC4/2018		AROMATICS PVT. LTD	ALC4/2020			Deferred
				17.04.2020
59	HQ File<br>:01/82/050/02466/AM19/		RLA File<br>:07/24/040/00305/AM18/	Lic.No/Date:0710112820<br>13.02.2018			Defer Date:
	Decision:The Committee	considered the case as per agenda in the presence of technical			experts and it
	was noted that the firm vide its e-mail dated 16.11.2019 has furnished its reply. Deferred for					comments of
	TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 16.11.2019 has furnished its reply. Deferred for comments of TE.

60	Case No.:82/10/82-ALC4/2018	Party Name:FRESENIUS KABI<br>INDIA PRIVATE LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/00369/AM19/	RLA File<br>:03/94/040/00911/AM18/	Lic.No/Date:0310819230<br>19.02.2018	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 14.10.2019 has furnished its reply to the query raised during PH<br>on 20.09.2019. Deferred for comments of TE.

ce of technical experts and it was noted that the firm vide its e-mail dated 14.10.2019 has furnished its reply to the query raised during PH on 20.09.2019. Deferred for comments of TE.||||

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 14.10.2019 has furnished its reply to the query raised during PH on 20.09.2019. Deferred for comments of TE.

61	Case No.:93/10/82-ALC4/2018	Party Name:YASHO<br>INDUSTRIES PVT.LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00380/AM19/	RLA File<br>:03/95/040/01007/AM18/	Lic.No/Date:0310819263<br>20.02.2018	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>noted that the firm vide its letter dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its letter dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

62	<br>Case No.:47/13/82-ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01025/AM19/	RLA File<br>:09/24/040/00587/AM18/	Lic.No/Date:0910066003<br>20.02.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/01025/AM19/|RLA File :09/24/040/00587/AM18/|Lic.No/Date:0910066003 20.02.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

63	Case No.:186/13/82-<br>ALC4/2018	Party Name:SONGWON<br>SPECIALTY CHEMICALS<br>INDIA PVT. LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01164/AM19/	RLA File<br>:34/24/040/00341/AM18/	Lic.No/Date:3410043908<br>22.02.2018	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 01.11.2019 has furnished its reply. Deferred for comments of<br>TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 01.11.2019 has furnished its reply. Deferred for comments of TE.

Case No.:286/4/82-ALC4/2018 Party Name:SURVIVAL Meet No/Date:1/82- Status: TECHNOLOGIES PVT.LTD. ALC4/2020 Deferred 17.04.2020 HQ File RLA File Lic.No/Date:0310819412 Defer Date: 64 :01/82/050/00286/AM19/ :03/95/040/00993/AM18/ 26.02.2018 Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 20.06.2019 has furnished its reply . Deferred for comments of TE.

mmittee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 20.06.2019 has furnished its reply . Deferred for comments of TE.

65	<br>Case No.:125/13/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01103/AM19/	RLA File<br>:09/24/040/00611/AM18/	Lic.No/Date:0910066054<br>12.03.2018	Defer Date:
	Decision:Deferred for comments of TE.

66	Case No.:33/13/82-ALC4/2018	Party Name:VISWAAT<br>CHEMICALS LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01011/AM19/	RLA File<br>:03/95/040/01027/AM18/	Lic.No/Date:0310819857<br>16.03.2018	Defer Date:
	Decision:The firm vide email dated. 14.02.2020 has stated that due to oversight, the application was<br>filled for ratification of norms instead of repeat norms. Accordingly they have requested to consider the<br>norms for the licence number 0310819857 dated 16.03.2018 as Repeat Norms basis.

Decision: The firm vide email dated. 14.02.2020 has stated that due to oversight, the application was filled for ratification of norms instead of repeat norms. Accordingly they have requested to consider the norms for the licence number 0310819857 dated 16.03.2018 as Repeat Norms basis.

ication was filled for ratification of norms instead of repeat norms. Accordingly they have requested to consider the norms for the licence number 0310819857 dated 16.03.2018 as Repeat Norms basis.

67	Case No.:127/13/82-<br>ALC4/2018	Party Name:SPANSULES<br>FORMULATIONS	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01105/AM19/	RLA File<br>:09/24/040/00619/AM18/	Lic.No/Date:0910066066<br>20.03.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 03.09.2019 has furnished its reply. Deferred for comments of TE.

68	Case No.:258/12/82-<br>ALC4/2018	Party Name:SYNTHO<br>CHIRALS PRIVATE LIMITED	<br>Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00885/AM19/	RLA File<br>:09/24/040/00669/AM18/	Lic.No/Date:0910066087<br>26.03.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 25.02.2020 has furnished its reply. Deferred for comments of TE.

69	<br>Case No.:126/13/82-<br>ALC4/2018	Party Name:OPTRIX<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01104/AM19/	RLA File<br>:09/24/040/00639/AM18/	Lic.No/Date:0910066086<br>26.03.2018	Defer Date:
	Decision:Deferred for comments of TE.

-|---|---|---|---| || HQ File :01/82/050/01104/AM19/|RLA File :09/24/040/00639/AM18/|Lic.No/Date:0910066086 26.03.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

Case No.:5/10/82-ALC4/2018	Party Name:DCM SHRIRAM	Meet No/Date:1/82-	Status:
	INDUSTRIES LTD,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0510406067	Defer Date:
:01/82/050/00292/AM19/	:05/23/040/00515/AM18/	09.04.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 70 Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020:

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield on molar basis at every stage

71	Case No.:1014/15/82-<br>ALC4/2018	Party Name:TADIMETY<br>AROMATICS PVT. LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02471/AM19/	RLA File<br>:07/24/040/00361/AM18/	Lic.No/Date:0710113089<br>10.04.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 16.11.2019 has furnished its reply. Deferred for comments of TE.

r Date:| ||**Decision:**The Committee considered the case as per agenda and it was noted that the firm vide its e-mail dated 16.11.2019 has furnished its reply. Deferred for comments of TE.||||

72	<br>Case No.:261/12/82-<br>ALC4/2018	<br>Case No.:261/12/82-<br>ALC4/2018	Party Name:AKTINOS<br>HEALTHCARE PRIVATE<br>LIMITED		Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00888/AM19/		RLA File<br>:09/24/040/00668/AM18/		Lic.No/Date:0910066131<br>11.04.2018		Defer Date:
	Decision:Deferred for comments of TE.

73	<br>Case No.:156/13/82-<br>ALC4/2018	Party Name:SMS<br>LIFESCIENCES INDIA<br>LIMITED		Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020		Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01134/AM19/	RLA File<br>:09/24/040/00654/AM18/		Lic.No/Date:0910066137<br>12.04.2018		Defer Date:
	Decision:Deferred for comments of TE.

Deferred**|| || HQ File :01/82/050/01134/AM19/|RLA File :09/24/040/00654/AM18/||Lic.No/Date:0910066137 12.04.2018||Defer Date:|| ||**Decision:**Deferred for comments of TE.|||||||

	Case No.:26/15/82-ALC4/2018Party Name:GLAND<br>Meet No/Date:1/82-		Status:
	CHEMICALS PVT LTD<br>ALC4/2020		Deferred
	17.04.2020
74	HQ File<br>:01/82/050/01483/AM19/<br>RLA File<br>:09/24/040/00008/AM19/<br>Lic.No/Date:0910066148<br>17.04.2018		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

	Case No.:122/13/82-	Party Name:SUVEN LIFE	Meet No/Date:1/82-	Status:
	ALC4/2018	SCIENCES LIMITED	ALC4/2020	Deferred
			17.04.2020
75	HQ File	RLA File	Lic.No/Date:0910066156	Defer Date:
	:01/82/050/01100/AM19/	:09/24/040/00024/AM19/	18.04.2018
	Decision:Deferred for comments of TE.

|||||17.04.2020||| |75||HQ File||RLA File||Lic.No/Date:0910066156||Defer Date:| |||:01/82/050/01100/AM19/||:09/24/040/00024/AM19/||18.04.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:6/15/82-	Party Name:AUROBINDO	Meet No/Date:1/82-	Status:
	ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
			17.04.2020
76	HQ File	RLA File	Lic.No/Date:0910066157	Defer Date:
	:01/82/050/01463/AM19/	:09/24/040/00015/AM19/	18.04.2018
	Decision:Deferred for comments of TE.

	Case No.:153/12/82-	Party Name:ETERNIS FINE	Meet No/Date:1/82-	Status:
	ALC4/2018	CHEMICALS LIMITED,	ALC4/2020	Deferred
			17.04.2020
77	HQ File	RLA File	Lic.No/Date:0310820647	Defer Date:
	:01/82/050/00780/AM19/	:03/94/040/00055/AM19/	25.04.2018
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail
	dated 17.06.2019 has furnished its reply. Deferred for comments of		TE.

Case No.:121/13/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066198	Defer Date:
:01/82/050/01099/AM19/	:09/24/040/00044/AM19/	04.05.2018

--|---| |ALC4/2018||LIMITED||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0910066198||Defer Date:| |:01/82/050/01099/AM19/||:09/24/040/00044/AM19/||04.05.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts 78 and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

79	<br>Case No.:225/10/82-<br>ALC4/2018	Party Name:DR J<br>PHARMACHEM PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00512/AM19/	RLA File<br>:31/83/040/00014/AM19/	Lic.No/Date:3110067038<br>07.05.2018	Defer Date:
	Decision:Deferred for comments of TE.

80	<br>Case No.:107/13/82-<br>ALC4/2018	Party Name:OPTRIX<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01085/AM19/	RLA File<br>:09/24/040/00006/AM19/	Lic.No/Date:0910066210<br>09.05.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/01085/AM19/|RLA File :09/24/040/00006/AM19/|Lic.No/Date:0910066210 09.05.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

81	<br>Case No.:250/10/82-<br>ALC4/2018	Party Name:AETHER<br>INDUSTRIES LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00537/AM19/	RLA File<br>:52/24/040/00016/AM19/	Lic.No/Date:5210042638<br>10.05.2018	Defer Date:
	Decision:Deferred for comments of TE.

82	Case No.:196/12/82-<br>ALC4/2018	Party Name:SHREE BANKEY<br>BEHARI LAL FLAVORS	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Approved
	HQ File<br>:01/82/050/00823/AM19/	RLA File<br>:05/24/040/00067/AM19/	Lic.No/Date:0510406412<br>10.05.2018
	<br>Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting<br>no.<br>13/82-ALC4/2019<br>dated<br>31.01.2020, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied<br>by the firm, whichever is less:<br>Export product<br>Qty.<br>Sl.<br>No.<br>Import items<br>Qty.<br>L-MENTHOL /MENTHOL<br>(LAVEO) / MENTHOL(L) / LIQUID<br>MENTHOL<br>1 kg<br>1<br>META - CRESOL ABOVE<br>98.5% PURE<br>0.922 kg<br>2<br>ISO PROPYL ALCOHOL<br>0.543 kg<br>3<br>ARROWZYME/LIPASE<br>AMANO IME<br>0.01 kg<br>RA concerned maytake further necessaryaction asper above decision of NC.

98.5% PURE 0.922 kg 2 ISO PROPYL ALCOHOL 0.543 kg 3 ARROWZYME/LIPASE AMANO IME 0.01 kg RA concerned maytake further necessaryaction asper above decision of NC.||||

Case No.:366/15/82-	Party Name:WINTAC	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0710113260	Defer Date:
:01/82/050/01823/AM19/	:07/24/040/00008/AM19/	10.05.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts 83 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

	Case No.:120/13/82-	Party Name:ORTIN	Meet No/Date:1/82-	Status:
	ALC4/2018	LABORATORIES LTD	ALC4/2020	Deferred
			17.04.2020
84	HQ File	RLA File	Lic.No/Date:0910066236	Defer Date:
	:01/82/050/01098/AM19/	:09/24/040/00614/AM18/	15.05.2018
	Decision:Deferred for comments of TE.

|||||17.04.2020||| |84||HQ File||RLA File||Lic.No/Date:0910066236||Defer Date:| |||:01/82/050/01098/AM19/||:09/24/040/00614/AM18/||15.05.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:18/13/82-	Party Name:SMS	Meet No/Date:1/82-	Status:
	ALC4/2018	LIFESCIENCES INDIA	ALC4/2020	Deferred
		LIMITED	17.04.2020
85	HQ File	RLA File	Lic.No/Date:0910066242	Defer Date:
	:01/82/050/00996/AM19/	:09/24/040/00067/AM19/	18.05.2018
	Decision:Deferred for comments of TE.

Case No.:168/12/82-	Party Name:MANGALAM	Meet No/Date:1/82-	Status:
ALC4/2018	ORGANICS LIMITED	ALC4/2020	Deferred
	FORMERLY DUJODWALA	17.04.2020
	PRODU
HQ File	RLA File	Lic.No/Date:0310821107	Defer Date:
:01/82/050/00795/AM19/	:03/95/040/01140/AM18/	21.05.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 86 Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020:

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage

y Reminder on 31.10.2019 and Final Reminder on 13.02.2020:

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage

	Case No.:373/15/82-	Party Name:TADIMETY	Meet No/Date:1/82-	Status:
	ALC4/2018	AROMATICS PVT. LTD	ALC4/2020	Deferred
			17.04.2020
87	HQ File	RLA File	Lic.No/Date:0710113330	Defer Date:
	:01/82/050/01830/AM19/	:07/24/040/00046/AM19/	25.05.2018
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail
	dated 16.11.2019 has furnished its reply. Deferred for comments of		TE.

	Case No.:39/13/82-ALC4/2018	Party Name:ORTIN	Meet No/Date:1/82-	Status:
		LABORATORIES LTD	ALC4/2020	Deferred
			17.04.2020
88	HQ File	RLA File	Lic.No/Date:0910066291	Defer Date:
	:01/82/050/01017/AM19/	:09/24/040/00082/AM19/	01.06.2018
	Decision:Deferred for comments of TE.

Case No.:376/15/82-	Party Name:GRANULES	Meet No/Date:1/82-	Status: Deferred
ALC4/2018	INDIA LIMITED	ALC4/2020
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066295	Defer Date:
:01/82/050/01833/AM19/	:09/24/040/00099/AM19/	04.06.2018

|---|---|---| |ALC4/2018||INDIA LIMITED||ALC4/2020||| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0910066295||Defer Date:| |:01/82/050/01833/AM19/||:09/24/040/00099/AM19/||04.06.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts 89 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

	Case No.:378/15/82-<br>Party Name:JODAS EXPOIM<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>PVT.LTD<br>ALC4/2020		Deferred
	17.04.2020
90	HQ File<br>:01/82/050/01835/AM19/<br>RLA File<br>:05/23/040/00080/AM19/<br>Lic.No/Date:0510406733<br>05.06.2018		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

|||available. Hence, it was decided to call for a copy of 4.07 application of the subject advance|authorization|| |||directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.|||

	Case No.:379/15/82-	Party Name:JODAS EXPOIM	Meet No/Date:1/82-	Status:
	ALC4/2018	PVT.LTD	ALC4/2020	Deferred
			17.04.2020
91	HQ File	RLA File	Lic.No/Date:0510406734	Defer Date:
	:01/82/050/01836/AM19/	:05/23/040/00070/AM19/	05.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued
	Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

de letter dated 10.10.2019.|||||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

	Case No.:380/15/82-<br>Party Name:JODAS EXPOIM<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>PVT.LTD<br>ALC4/2020		Deferred
	17.04.2020
92	HQ File<br>:01/82/050/01837/AM19/<br>RLA File<br>:05/23/040/00022/AM19/<br>Lic.No/Date:0510406736<br>05.06.2018		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:279/10/82-		Party Name:J.B. CHEMICALS	Meet No/Date:1/82-	Status:
	ALC4/2018		& PHARMACEUTICALS	ALC4/2020	Deferred
			LIMITED	17.04.2020
93	HQ File<br>:01/82/050/00566/AM19/		RLA File<br>:03/94/040/00207/AM19/	Lic.No/Date:0310821556<br>08.06.2018	Defer Date:
	Decision:The Committee	considered the case as per agenda in the presence of technical experts and it
	was noted that the firm vide its		e-mail dated 14.02.2020 has furnished its reply. Deferred for comments of
	TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 14.02.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:81/12/82-ALC4/2018	Party Name:KOPRAN	Meet No/Date:1/82-	Status:
		RESEARCH LABORATORIES	ALC4/2020	Deferred
		LTD.	17.04.2020
94	HQ File	RLA File	Lic.No/Date:0310821554	Defer Date:
	:01/82/050/00708/AM19/	:03/94/040/00194/AM19/	08.06.2018
	Decision:Deferred for comments of TE.

TD.||17.04.2020||| |94||HQ File||RLA File||Lic.No/Date:0310821554||Defer Date:| |||:01/82/050/00708/AM19/||:03/94/040/00194/AM19/||08.06.2018||| |||**Decision:**Deferred for comments of TE.|||||||

Case No.:60/15/82-	Party Name:ALPHAMED	Meet No/Date:1/82-	Status:
ALC4/2018	FORMULATIONS P LTD.	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066310	Defer Date:
:01/82/050/01517/AM19/	:09/24/040/00075/AM19/	08.06.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts 95 and it was noted that the firm still has not furnished the 4.07 application of subject Advancer Authorization as asked for by NC-3 in its Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 21.02.2020 as per Policy Circular No. 23/2015-20 dated 15.05.2019.

ish a copy of 4.07 application of the subject advance authorization immediately to this Directorate as per Policy Circular No. 23/2015-20, dated 15.05.2019, failing which its case will be rejected.


96	<br>Case No.:383/15/82-<br>ALC4/2018<br>HQ File<br>	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:1/82-<br>ALC4/2020<br>	Status:<br>Deferred
			17.04.2020
		RLA File<br>	Lic.No/Date:0510406800<br>	Defer Date:
	:01/82/050/01840/AM19/	:05/23/040/00121/AM19/	08.06.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

97	Case No.:385/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01842/AM19/	RLA File<br>:05/23/040/00501/AM18/	Lic.No/Date:0510406802<br>08.06.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

otice vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

Case No.:59/13/82-ALC4/2018	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066318	Defer Date:
:01/82/050/01037/AM19/	:09/24/040/00106/AM19/	11.06.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following informationas asked for by NC-3 in its 98 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:35/13/82- Party Name:VIVIMED LABS Meet No/Date:1/82- Status: ALC4/2018 LIMITED ALC4/2020 Deferred 17.04.2020 HQ File RLA File Lic.No/Date:0910066375 Defer Date: :01/82/050/01013/AM19/ :09/24/040/00136/AM19/ 22.06.2018

LABS Meet No/Date:1/82- Status: ALC4/2018 LIMITED ALC4/2020 Deferred 17.04.2020 HQ File RLA File Lic.No/Date:0910066375 Defer Date: :01/82/050/01013/AM19/ :09/24/040/00136/AM19/ 22.06.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following informationas asked for by NC-3 in its 99 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:71/13/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066374	Defer Date:
:01/82/050/01049/AM19/	:09/24/040/00134/AM19/	22.06.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following informationas asked for by NC-3 in its 100 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

2-ALC4/2019 dated 17.01.2020** , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:76/13/82-	Party Name:VIVIMED LABS	Meet No/Date:1/82-	Status:
ALC4/2018	LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066376	Defer Date:
:01/82/050/01054/AM19/	:09/24/040/00135/AM19/	22.06.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following informationas asked for by NC-3 in its 101 Meeting No. 12/82-ALC4/2019 dated 17.01.2020 , followed by Reminder on 13.02.2020 :

(i) Justification for low yield in the process alongwith documentary evidence. (ii) Complete set of 4.07 application.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

ntary evidence. (ii) Complete set of 4.07 application.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

102	Case No.:274/10/82-<br>ALC4/2018	Party Name:MELOG<br>SPECIALITY CHEMICALS<br>PVT. LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00561/AM19/	RLA File<br>:03/95/040/00235/AM19/	Lic.No/Date:0310821895<br>25.06.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 07.11.2019 has furnished its reply. Deferred for comments of TE.

103	<br>Case No.:185/13/82-<br>ALC4/2018	Party Name:SPC LIFE<br>SCIENCES PVT. LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01163/AM19/	RLA File<br>:34/24/040/00109/AM19/	Lic.No/Date:3410044282<br>26.06.2018	Defer Date:
	Decision:Deferred for comments of TE.

104	<br>Case No.:117/13/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01095/AM19/	RLA File<br>:09/24/040/00150/AM19/	Lic.No/Date:0910066395<br>27.06.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

--|---|---|---|---| || HQ File :01/82/050/01095/AM19/|RLA File :09/24/040/00150/AM19/|Lic.No/Date:0910066395 27.06.2018| Defer Date:| ||**Decision:**Deferred for comments of TE.||||

105	<br>Case No.:12/15/82-ALC4/2018	Party Name:AURORE LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01469/AM19/	RLA File<br>:09/24/040/00113/AM19/	Lic.No/Date:0910066403<br>28.06.2018	Defer Date:
	Decision:Deferred for comments of TE.

106	<br>Case No.:221/12/82-<br>ALC4/2018	Party Name:IOL CHEMICALS<br>AND PHARMACEUTICALS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00848/AM19/	RLA File<br>:30/24/040/00017/AM19/	Lic.No/Date:3010104375<br>29.06.2018	Defer Date:
	Decision:Deferred for comments of TE.

107	Case No.:417/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01874/AM19/	RLA File<br>:05/23/040/00167/AM19/	Lic.No/Date:0510407069<br>04.07.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

otice vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

108	Case No.:418/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	<br>Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01875/AM19/	RLA File<br>:05/23/040/00163/AM19/	Lic.No/Date:0510407077<br>04.07.2018	<br>Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

109	Case No.:419/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	<br>Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01876/AM19/	RLA File<br>:05/23/040/00164/AM19/	Lic.No/Date:0510407078<br>04.07.2018	<br>Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

78 04.07.2018| Defer Date:| ||**Decision:**The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.||||

Case No.:58/15/82-ALC4/2018 Party Name:AUROBINDO Meet No/Date:1/82- Status: PHARMA LIMITED ALC4/2020 Approved 17.04.2020 HQ File RLA File Lic.No/Date:0910066418 :01/82/050/01515/AM19/ :09/24/040/00168/AM19/ 04.07.2018 Decision: The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:

	Case No.:58/15/82-ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Approved
	HQ File<br>:01/82/050/01515/AM19/	RLA File<br>:09/24/040/00168/AM19/				Lic.No/Date:0910066418<br>04.07.2018

2020 17.04.2020|Status: Approved| |---|---|---|---|---|---|---|---|---| ||HQ File :01/82/050/01515/AM19/|RLA File :09/24/040/00168/AM19/||||Lic.No/Date:0910066418 04.07.2018||| |110| **Decision:**The Committee considered the cases as per agenda and in the light of earlier decision taken in meeting no. 1/82-ALC4/2019 dated 03.06.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less: Export product Qty. Sl. No. Import items Qty. CEFEPIME FOR INJECTION 1 kg 1 Cefepime Hydrochloride 0.655 kg 2 L - Arginine 1.816 kg 3 Acetone 0.37 kg 4 Isopropyl Alcohol 0.392 kg 5 Methanol Relevant as per packing policy RA concerned maytake further necessaryaction asper above decision of NC.|||||||| || Export product||Qty.|Sl. No.|Import items||Qty.|| ||CEFEPIME FOR INJECTION||1 kg|1|Cefepime Hydrochloride||0.655 kg|| |||||2|L - Arginine||1.816 kg|| |||||3|Acetone||0.37 kg|| |||||4|Isopropyl Alcohol||0.392 kg|| |||||5|Methanol||Relevant as per packing policy|| ||RA concerned maytake further necessaryaction asper above decision of NC.||||||||

111	<br>Case No.:389/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01846/AM19/	RLA File<br>:08/24/040/00030/AM19/	Lic.No/Date:0810142955<br>04.07.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/01846/AM19/|RLA File :08/24/040/00030/AM19/|Lic.No/Date:0810142955 04.07.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

112	Case No.:617/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02074/AM19/	RLA File<br>:05/23/040/00166/AM19/	Lic.No/Date:0510407070<br>04.07.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

113	Case No.:96/12/82-ALC4/2018	Party Name:STERLING<br>AUXILIARIES PVT LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00723/AM19/	RLA File<br>:03/95/040/00332/AM19/	Lic.No/Date:0310822247<br>11.07.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 31.10.2019 has furnished its reply. Deferred for comments of TE.

Date:| ||**Decision:**The Committee considered the case as per agenda and it was noted that the firm vide its e-mail dated 31.10.2019 has furnished its reply. Deferred for comments of TE.||||

114	<br>Case No.:46/15/82-ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01503/AM19/	RLA File<br>:09/24/040/00181/AM19/	Lic.No/Date:0910066442<br>11.07.2018	Defer Date:
	Decision:Deferred for comments of TE.

Case No.:100/13/82-	Party Name:RA CHEM	Meet No/Date:1/82-	Status:
ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066457	Defer Date:
:01/82/050/01078/AM19/	:09/24/040/00188/AM19/	13.07.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 115 Meeting No. 8/82-ALC4/2019 dated 06.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020.

(i) Drug Manufacturing License (DML) of the export product showing approved composition.

Case No.:189/13/82-	Party Name:YASH RASAYAN	Meet No/Date:1/82-	Status:
ALC4/2018	& CHEMICALS	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044333	Defer Date:
:01/82/050/01167/AM19/	:34/24/040/00114/AM19/	16.07.2018

--| |ALC4/2018||& CHEMICALS||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:3410044333||Defer Date:| |:01/82/050/01167/AM19/||:34/24/040/00114/AM19/||16.07.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 116 Meeting No. 8/82-ALC4/2019 dated 06.09.2019, followed by Reminder on 31.10.2019 and Final Reminder on 13.02.2020.

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage.

117	Case No.:432/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	<br>Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01889/AM19/	RLA File<br>:05/23/040/00183/AM19/	Lic.No/Date:0510407217<br>17.07.2018	<br>Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

otice vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

Case No.:444/15/82-	Party Name:OPTIMUS	Meet No/Date:1/82-	Status:
ALC4/2018	DRUGS PRIVATE LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0910066488	Defer Date:
:01/82/050/01901/AM19/	:09/24/040/00193/AM19/	19.07.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 18.03.2020 : 118

(i) Complete and balanced chemical reactions with % yield on molar basis for each step. (ii) Technical justification alongwith catalogue for LYOPHILIZED ENZYME POWDER. (iii) End-use of the export product.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

ED ENZYME POWDER. (iii) End-use of the export product.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

119	Case No.:448/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01905/AM19/	RLA File<br>:09/24/040/00200/AM19/	Lic.No/Date:0910066511<br>24.07.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

Case No.:239/13/82-	Party Name:KEVA	Meet No/Date:1/82-	Status:
ALC4/2018	FRAGRANCES PRIVATE	ALC4/2020	Deferred
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0310822723	Defer Date:
:01/82/050/01217/AM19/	:03/94/040/00390/AM19/	31.07.2018

18**||FRAGRANCES PRIVATE||ALC4/2020||Deferred| |||LIMITED||17.04.2020||| |HQ File||RLA File||Lic.No/Date:0310822723||Defer Date:| |:01/82/050/01217/AM19/||:03/94/040/00390/AM19/||31.07.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 31.10.2019 and Final Reminder 120 on 18.03.2020.

(i) Exact name of the export product. (ii) Crude to finished product. (iii) Past production consumption data.

	Case No.:460/15/82-<br>Party Name:WINTAC<br>Meet No/Date:1/82-		Status:
	ALC4/2018<br>LIMITED,<br>ALC4/2020		Deferred
	17.04.2020
121	HQ File<br>:01/82/050/01917/AM19/<br>RLA File<br>:07/24/040/00087/AM19/<br>Lic.No/Date:0710113686<br>06.08.2018		Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not
	available. Hence, it was decided to call for a copy of 4.07 application of the subject advance	authorization
	directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

	Case No.:172/13/82-	Party Name:TIDE		Meet No/Date:1/82-	Status:
	ALC4/2018	INDUSTRIES		ALC4/2020	Deferred
				17.04.2020
122	HQ File	RLA File		Lic.No/Date:3410044399	Defer Date:
	:01/82/050/01150/AM19/	:34/24/040/00094/AM19/		08.08.2018
	Decision:The Committee considered the case as per agenda		and it was noted that the firm vide its e-
	mail dated 01.11.2019 has furnished its reply. Deferred for comments of TE.

	Case No.:134/13/82-	Party Name:YASHO	Meet No/Date:1/82-	Status:
	ALC4/2018	INDUSTRIES LIMITED	ALC4/2020	Deferred
			17.04.2020
123	HQ File	RLA File	Lic.No/Date:0310822942	Defer Date:
	:01/82/050/01112/AM19/	:03/95/040/00445/AM19/	09.08.2018
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail
	dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

cision:**The Committee considered the case as per agenda and it was noted that the firm vide its e-mail||||||| |||dated 24.10.2019 has furnished its reply. Deferred for comments of TE.|||||||

124	Case No.:326/13/82-<br>ALC4/2018	Party Name:BALAJI AMINES<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01304/AM19/	RLA File<br>:31/83/040/00082/AM19/	Lic.No/Date:3110067147<br>20.08.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 26.11.2019 has furnished its reply. Deferred for comments of TE.

125	Case No.:470/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01927/AM19/	RLA File<br>:05/23/040/00232/AM19/	Lic.No/Date:0510407550<br>20.08.2018	Defer Date:
	Decision:<br>The Committee considered the case as per agenda and it was observed that the firm was<br>issued Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

otice vide letter dated 10.10.2019.||||

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

126	Case No.:471/15/82-<br>ALC4/2018	Party Name:JODAS EXPOIM<br>PVT.LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01928/AM19/	RLA File<br>:05/23/040/00231/AM19/	Lic.No/Date:0510407551<br>20.08.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

127	Case No.:472/15/82-<br>ALC4/2018	Party Name:WINTAC<br>LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01929/AM19/	RLA File<br>:07/24/040/00131/AM19/	Lic.No/Date:0710113733<br>20.08.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

t available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.||||

Case No.:142/13/82-	Party Name:PALADIN	Meet No/Date:1/82-	Status:
ALC4/2018	PAINTS AND CHEMICALS	ALC4/2020	Deferred
	PVT. LTD.,	17.04.2020
HQ File	RLA File	Lic.No/Date:0310823254	Defer Date:
:01/82/050/01120/AM19/	:03/95/040/00456/AM19/	24.08.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 128 Meeting No. 9/82-ALC4/2019 dated 18.10.2019, followed by Reminder on 09.12.2019 and Final Reminder on 18.03.2020.

(i) Complete 4E with all technical details chemistry, molecular weight, stoichiometric reaction and % of yield at every stage.

Case No.:209/13/82-	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
ALC4/2018	NOVOCHEM	ALC4/2020	Deferred
	TECHNOLOGIES LTD	17.04.2020
HQ File	RLA File	Lic.No/Date:3110067162	Defer Date:
:01/82/050/01187/AM19/	:31/83/040/00081/AM19/	24.08.2018

018**||NOVOCHEM||ALC4/2020||Deferred| |||TECHNOLOGIES LTD||17.04.2020||| |HQ File||RLA File||Lic.No/Date:3110067162||Defer Date:| |:01/82/050/01187/AM19/||:31/83/040/00081/AM19/||24.08.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 9/82-ALC4/2019 dated 18.10.2019, followed by Reminder on 09.12.2019 and Final Reminder 129 on 18.03.2020.

(i) Catalogue of OCP. (ii) Certificate of Analysis (CoA) of OCP. (iii) Percentage yield on molar basis.

130	Case No.:475/15/82-<br>ALC4/2018	Party Name:WINTAC<br>LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01932/AM19/	RLA File<br>:07/24/040/00098/AM19/	Lic.No/Date:0710113754<br>24.08.2018	<br>Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

131	Case No.:368/13/82-<br>ALC4/2018	Party Name:DANOPHARM<br>CHEMICALS PRIVATE LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01346/AM19/	RLA File<br>:03/94/040/00340/AM19/	Lic.No/Date:0310823354<br>28.08.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm<br>dated 28.11.2019 has furnished its reply. Deferred for comments of TE.			vide its letter

132	Case No.:369/13/82-<br>ALC4/2018	Party Name:DANOPHARM<br>CHEMICALS PRIVATE<br>LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01347/AM19/	RLA File<br>:03/94/040/00413/AM19/	Lic.No/Date:0310823358<br>28.08.2018	<br>Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the<br>dated 28.11.2019 has furnished its reply. Deferred for comments of TE.			firm vide its letter

Decision: The Committee considered the case as per agenda and it was noted that the firm vide its letter dated 28.11.2019 has furnished its reply. Deferred for comments of TE.

de its letter|

Decision: The Committee considered the case as per agenda and it was noted that the firm vide its letter dated 28.11.2019 has furnished its reply. Deferred for comments of TE.

133	<br>Case No.:35/15/82-ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01492/AM19/	RLA File<br>:09/24/040/00249/AM19/	Lic.No/Date:0910066604<br>29.08.2018	Defer Date:
	Decision:Deferred for comments of TE.

134	<br>Case No.:492/15/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01949/AM19/	RLA File<br>:09/24/040/00245/AM19/	Lic.No/Date:0910066600<br>29.08.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

135	<br>Case No.:84/13/82-ALC4/2018	Party Name:SRINI<br>PHARMACEUTICALS<br>PRIVATE LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01062/AM19/	RLA File<br>:09/24/040/00251/AM19/	Lic.No/Date:0910066620<br>03.09.2018	Defer Date:
	Decision:Deferred for comments of TE.

-|---|---|---|---| || HQ File :01/82/050/01062/AM19/|RLA File :09/24/040/00251/AM19/|Lic.No/Date:0910066620 03.09.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

	Case No.:88/13/82-<br>ALC4/2018	Party Name:SATYADEVA<br>PHARMACEUTICALS PVT<br>LTD	Party Name:SATYADEVA<br>PHARMACEUTICALS PVT<br>LTD	Party Name:SATYADEVA<br>PHARMACEUTICALS PVT<br>LTD		Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020
	HQ File<br>:01/82/050/01066/AM19/	RLA File<br>:09/24/040/00247/AM19/				Lic.No/Date:091006662<br>03.09.2018	3
	Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting<br>no.<br>7/82-ALC4/2019<br>dated<br>06.09.2019, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as
	applied by the firm, whichever is less:<br>d<br>
			l
	Export Prouct<br>(2S,3S,5S)-2-Amino-3-<br>Hydroxy-5-(1-Tetra hydro<br>pyramid-2-only)-3-Methyl<br>butanoyl)	Qty	S.<br>No.	Import Items			Qty
		1 kg	1	DAH-II			1.13 kg
							6.74 kg
			2	1,2 DIMETH	XYETHANE
			3	SODIUM BO	ROHYDRIDE		0.406 kg
					<br>
	<br>Amino-1,6-diphenyl<br>		4	METHANE<br>(OR)METHA	SULFONIC<br>ACID<br>NESULPHONIC ACID		1.57 kg
	Hexane-s-pyro glutamate<br>(THP)		5	<br>ISOPROPYL ALCOHOL			1.27 kg
			6	Triethanolamine(99%)			1.167 kg
136			7	<br>N.N-DIMETH<br>DIMETHYL	<br>YL ACETAMIDE (OR)<br>ACETAMIDE		1.60 kg

|| ||Hexane-s-pyro glutamate (THP)||5| ISOPROPYL ALCOHOL|||1.27 kg||| ||||6|Triethanolamine(99%)|||1.167 kg||| |136|||7| N.N-DIMETH DIMETHYL| YL ACETAMIDE (OR) ACETAMIDE||1.60 kg||| ||||8|L-VALINE|||0.630 kg||| ||||9|MCF|||1.00 kg||| ||||10|MDC|||3.25 kg||| ||||11|ACERLONITRILE|||0.30 kg||| ||||12|METHANOL|||3.30 kg||| ||||13|METHYL TETR-BUTYL ETHER|||2.45 kg||| ||||| (OR)TERTIARY BUTYL METHYL ETHER|||||| ||||14|N,N-CARBO|NYL DIMIDAZOLE||0.443 kg||| ||||15|AMMONIUM|FORMATE||0.500 kg||| ||||16|DIMETHYL|FORMAMIDE||3.95 kg||| ||||17|L-PYROGLU|TAMIC ACID||0.295 kg||| ||||18|AMMONIUM|CHLORIDE||2.00 kg||| ||||19|PALLADIUM SPONGE (99.95% MIN)|||0.001 kg||| ||||||||||| ||RA concerned maytake further necessaryaction asper above decision of NC.|||||||||

137	<br>Case No.:502/15/82-<br>ALC4/2018<br>Party Name:SUVEN LIFE<br>SCIENCES LIMITED<br>HQ File<br>:01/82/050/01959/AM19/<br>RLA File<br>:09/24/040/00260/AM19/<br>Decision:Deferred for comments of TE.	Party Name:SUVEN LIFE<br>SCIENCES LIMITED<br>RLA File<br>:09/24/040/00260/AM19/	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
			Lic.No/Date:0910066621<br>03.09.2018	Defer Date:

LA File :09/24/040/00260/AM19/|Meet No/Date:1/82- ALC4/2020 17.04.2020|Status: Deferred| |---|---|---|---|---| ||||Lic.No/Date:0910066621 03.09.2018|Defer Date:| ||||||

138	<br>Case No.:435/13/82-<br>ALC4/2018	Party Name:DCM SHRIRAM<br>INDUSTRIES LTD,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01413/AM19/	RLA File<br>:05/23/040/00242/AM19/	Lic.No/Date:0510407689<br>05.09.2018	Defer Date:
	Decision:Deferred for comments of TE.

Case No.:44/15/82-ALC4/2018	Party Name:DISCOVERY	Meet No/Date:1/82-	Status:
	LABORATORIES PRIVATE	ALC4/2020	Deferred
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0910066631	Defer Date:
:01/82/050/01501/AM19/	:09/24/040/00283/AM19/	06.09.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 139 Meeting No. 3/82-ALC4/2019 dated 05.07.2019, followed by Reminder on 02.08.2019 and Final Reminder on 18.03.2020.

(i) Complete technical details as per Appendix 4E alongwith chemistry, Molecular weight and % of yield.

The requisite reply is still awaited from the firm. In view of above, the Committee decided to defer the case.

cal details as per Appendix 4E alongwith chemistry, Molecular weight and % of yield.

The requisite reply is still awaited from the firm. In view of above, the Committee decided to defer the case.

140	<br>Case No.:429/13/82-<br>ALC4/2018	Party Name:CADILA<br>HEALTHCARE LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01407/AM19/	RLA File<br>:08/24/040/00131/AM19/	Lic.No/Date:0810143413<br>07.09.2018	Defer Date:
	Decision:Deferred for comments of TE.

141	<br>Case No.:40/15/82-<br>ALC4/2018	Party Name:INCHEM<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01497/AM19/	RLA File<br>:09/24/040/00230/AM19/	Lic.No/Date:0910066657<br>11.09.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

142	<br>Case No.:41/15/82-<br>ALC4/2018	Party Name:INCHEM<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01498/AM19/	RLA File<br>:09/24/040/00261/AM19/	Lic.No/Date:0910066658<br>11.09.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

-|---|---|---| || HQ File :01/82/050/01498/AM19/|RLA File :09/24/040/00261/AM19/|Lic.No/Date:0910066658 11.09.2018| Defer Date:| ||**Decision:**Deferred for comments of TE.||||

143	<br>Case No.:17/7/82-<br>ALC4/2019	Party Name:GLOBAL<br>CALCIUM PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/00512/AM20/	RLA File<br>:07/24/040/00144/AM19/	Lic.No/Date:0710113843<br>12.09.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

144	<br>Case No.:400/13/82-<br>ALC4/2018	Party Name:J.B.<br>CHEMICALS &<br>PHARMACEUTICALS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01378/AM19/	RLA File<br>:03/94/040/00504/AM19/	Lic.No/Date:0310823779<br>17.09.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

145	<br>Case No.:519/15/82-<br>ALC4/2018	Party Name:SUVEN LIFE<br>SCIENCES LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01976/AM19/	RLA File<br>:09/24/040/00288/AM19/	Lic.No/Date:0910066679<br>18.09.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

--|---|---|---|---| || HQ File :01/82/050/01976/AM19/|RLA File :09/24/040/00288/AM19/|Lic.No/Date:0910066679 18.09.2018| Defer Date:| ||**Decision:**Deferred for comments of TE.||||

146	Case No.:525/15/82-<br>ALC4/2018	Party Name:SHILPA<br>MEDICARE LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01982/AM19/	RLA File<br>:07/24/040/00164/AM19/	Lic.No/Date:0710113890<br>25.09.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

147	Case No.:176/13/82-<br>ALC4/2018	Party Name:VOVANTIS<br>LABORATORIES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:3410044518<br>26.09.2018	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01154/AM19/	RLA File<br>:34/24/040/00145/AM19/		Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 03.04.2020 has furnished its reply. Deferred for comments of<br>TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 03.04.2020 has furnished its reply. Deferred for comments of TE.

Case No.:213/13/82-	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
ALC4/2018	NOVOCHEM	ALC4/2020	Deferred
	TECHNOLOGIES LTD	17.04.2020
HQ File	RLA File	Lic.No/Date:3110067177	Defer Date:
:01/82/050/01191/AM19/	:31/83/040/00094/AM19/	26.09.2018

018**||NOVOCHEM||ALC4/2020||Deferred| |||TECHNOLOGIES LTD||17.04.2020||| |HQ File||RLA File||Lic.No/Date:3110067177||Defer Date:| |:01/82/050/01191/AM19/||:31/83/040/00094/AM19/||26.09.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 148 Meeting No. 9/82-ALC4/2019 dated 18.10.2019, followed by Reminder on 09.12.2019 and Final Reminder on 18.03.2020.

(i) Exact chemical name of the export product.

149	Case No.:534/15/82-<br>ALC4/2018	Party Name:YASH RASAYAN<br>& CHEMICALS	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01991/AM19/	RLA File<br>:34/24/040/00184/AM19/	Lic.No/Date:3410044523<br>26.09.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

150	<br>Case No.:536/15/82-<br>ALC4/2018	Party Name:YASH RASAYAN<br>& CHEMICALS	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01993/AM19/	RLA File<br>:34/24/040/00185/AM19/	Lic.No/Date:3410044524<br>26.09.2018	Defer Date:
	Decision:Deferred for comments of TE.

151	<br>Case No.:112/13/82-<br>ALC4/2018	Party Name:VARAHI<br>PHARMA PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01090/AM19/	RLA File<br>:66/24/040/00004/AM19/	Lic.No/Date:6610000013<br>03.10.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

	Case No.:612/15/82-	Party Name:MANGALAM	Meet No/Date:1/82-	Status:
	ALC4/2018	ORGANICS LIMITED	ALC4/2020	Deferred
		(FORMERLY DUJODWALA	17.04.2020
152	HQ File	RLA File	Lic.No/Date:0310824148	Defer Date:
	:01/82/050/02069/AM19/	:03/95/040/00560/AM19/	03.10.2018
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail
	dated 04.11.2019 has furnished its reply. Deferred for comments of TE.

|**Decision:**The Committee considered the case as per agenda and it was noted that the firm vide its e-mail||||||| |||dated 04.11.2019 has furnished its reply. Deferred for comments of TE.|||||||

	Case No.:52/13/82-ALC4/2018	Party Name:S V LABS PVT	Meet No/Date:1/82-	Status:
		LTD	ALC4/2020	Deferred
			17.04.2020
153	HQ File	RLA File	Lic.No/Date:0910066711	Defer Date:
	:01/82/050/01030/AM19/	:09/24/040/00301/AM19/	04.10.2018
	Decision:Deferred for comments of TE.

	Case No.:562/15/82-	Party Name:ORTIN	Meet No/Date:1/82-	Status:
	ALC4/2018	LABORATORIES LTD	ALC4/2020	Deferred
			17.04.2020
154	HQ File	RLA File	Lic.No/Date:0910066712	Defer Date:
	:01/82/050/02019/AM19/	:09/24/040/00302/AM19/	04.10.2018
	Decision:Deferred for comments of TE.

	Case No.:565/15/82-	Party Name:S M S	Meet No/Date:1/82-	Status:
	ALC4/2018	PHARMACEUTICALS LTD	ALC4/2020	Deferred
			17.04.2020
155	HQ File	RLA File	Lic.No/Date:0910066716	Defer Date:
	:01/82/050/02022/AM19/	:09/24/040/00319/AM19/	04.10.2018
	Decision:Deferred for comments of TE.

||||17.04.2020||| |155||HQ File||RLA File||Lic.No/Date:0910066716||Defer Date:| |||:01/82/050/02022/AM19/||:09/24/040/00319/AM19/||04.10.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:567/15/82-	Party Name:VERVE HUMAN	Meet No/Date:1/82-	Status:
	ALC4/2018	CARE LABORATORIES	ALC4/2020	Deferred
			17.04.2020
156	HQ File	RLA File	Lic.No/Date:6110001546	Defer Date:
	:01/82/050/02024/AM19/	:61/24/040/00009/AM19/	04.10.2018
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail
	dated 09.08.2019 has furnished its reply. Deferred for comments of TE.

	Case No.:454/13/82-	Party Name:IND-SWIFT	Meet No/Date:1/82-	Status:
	ALC4/2018	LABORATORIES LTD.,	ALC4/2020	Deferred
			17.04.2020
157	HQ File	RLA File	Lic.No/Date:2210015989	Defer Date:
	:01/82/050/01432/AM19/	:22/24/040/00058/AM19/	05.10.2018
	Decision:Deferred for comments of TE.

7.04.2020||| |157||HQ File||RLA File||Lic.No/Date:2210015989||Defer Date:| |||:01/82/050/01432/AM19/||:22/24/040/00058/AM19/||05.10.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:569/15/82-	Party Name:JODAS EXPOIM	Meet No/Date:1/82-	Status:
	ALC4/2018	PVT.LTD	ALC4/2020	Deferred
			17.04.2020
158	HQ File	RLA File	Lic.No/Date:0510408024	Defer Date:
	:01/82/050/02026/AM19/	:05/23/040/00297/AM19/	08.10.2018
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued
	Show Cause Notice vide letter dated 10.10.2019.

Decision: The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.

	Case No.:570/15/82-		Party Name:JODAS EXPOIM	Meet No/Date:1/82-	Status:
	ALC4/2018		PVT.LTD	ALC4/2020	Deferred
				17.04.2020
159	HQ File		RLA File	Lic.No/Date:0510408025	Defer Date:
	:01/82/050/02027/AM19/		:05/23/040/00295/AM19/	08.10.2018
	Decision:The Committee considered the case as per agenda			and it was observed that the firm was issued
	Show Cause Notice vide letter	dated 10.10.2019.

295/AM19/||08.10.2018||| |||**Decision:**The Committee considered the case as per agenda||||and it was observed that the firm was issued||| |||Show Cause Notice vide letter|dated 10.10.2019.||||||

	Case No.:572/15/82-	Party Name:A.R. LIFE	Meet No/Date:1/82-	Status:
	ALC4/2018	SCIENCES PVT LTD	ALC4/2020	Deferred
			17.04.2020
160	HQ File	RLA File	Lic.No/Date:0910066726	Defer Date:
	:01/82/050/02029/AM19/	:09/24/040/00309/AM19/	08.10.2018
	Decision:Deferred for comments of TE.

	Case No.:224/13/82-	Party Name:ASTRAL	Meet No/Date:1/82-	Status:
	ALC4/2018	STERITECH PVT. LTD.	ALC4/2020	Deferred
			17.04.2020
161	HQ File	RLA File	Lic.No/Date:3410044573	Defer Date:
	:01/82/050/01202/AM19/	:34/24/040/00225/AM19/	10.10.2018
	Decision:Deferred for comments of TE.

||||17.04.2020||| |161||HQ File||RLA File||Lic.No/Date:3410044573||Defer Date:| |||:01/82/050/01202/AM19/||:34/24/040/00225/AM19/||10.10.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:582/15/82-<br>	Party Name:MACSON	Party Name:MACSON	Meet No/Date:1/82-	Meet No/Date:1/82-	Status:<br>
162	<br>ALC4/2018<br>HQ File<br>:01/82/050/02039/AM19/<br>Decision:The firm vide e	PRODUCTS<br>RLA File<br>		ALC4/2020<br>17.04.2020		Deferred
				Lic.No/Date:5210042<br>	796	Defer Date:
		:52/24/040/00039/AM19/		11.10.2018
		-mail dated 05.02.2020 has in	formed that they have not		taken any benefit
	against the subject advance authorization as they have not imported anything (as per the custom certified<br>non-utilization certificate).

163	Case No.:590/15/82-<br>ALC4/2018		Party Name:VERVE HUMA<br>CARE LABORATORIES	N	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020		Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02047/AM19/		RLA File<br>:61/24/040/00011/AM19/		Lic.No/Date:6110001<br>11.10.2018	553	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

r>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.|||||||

164	<br>Case No.:801/15/82-<br>ALC4/2018		Party Name:DEEPAK<br>PHENOLICS LIMITED		Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020		Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02258/AM19/		RLA File<br>:34/24/040/00230/AM19/		Lic.No/Date:3410044<br>11.10.2018	580	Defer Date:
	Decision:Deferred for comments of TE.

	Case No.:169/13/82-	Party Name:SPC LIFE	Meet No/Date:1/82-	Status:
	ALC4/2018	SCIENCES PVT. LTD.	ALC4/2020	Deferred
			17.04.2020
165	HQ File	RLA File	Lic.No/Date:3410044586	Defer Date:
	:01/82/050/01147/AM19/	:34/24/040/00211/AM19/	12.10.2018
	Decision:Deferred for comments of TE.

||||17.04.2020||| |165||HQ File||RLA File||Lic.No/Date:3410044586||Defer Date:| |||:01/82/050/01147/AM19/||:34/24/040/00211/AM19/||12.10.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:592/15/82-	Party Name:SRIAM LABS	Meet No/Date:1/82-	Status:
	ALC4/2018	PRIVATE LIMITED	ALC4/2020	Deferred
			17.04.2020
166	HQ File	RLA File	Lic.No/Date:0910066753	Defer Date:
	:01/82/050/02049/AM19/	:09/24/040/00338/AM19/	16.10.2018
	Decision:Deferred for comments of TE.

	Case No.:322/13/82-	Party Name:ANLON	Meet No/Date:1/82-	Status:
	ALC4/2018	HEALTHCARE	ALC4/2020	Deferred
		PRIVATELIMITED	17.04.2020
	HQ File	RLA File	Lic.No/Date:2410042548	Defer Date:
	:01/82/050/01300/AM19/<br>:24/24/040/00033/AM19/		24.10.2018
	Decision:The Committee considered the case as per online agenda in the presence of technical experts
167	and it was noted that	the firm still has not furnished the following information asked for by		NC-3 in its
	Meeting No.13/82-ALC4/2019 dated 31.01.2020, followed by Reminder on18.03.2020:
	(i)	Complete chemical reaction, molecular weight and % yield on molar basis for
		each step of manufacturing process.
	In view of above, the Committee decided to issueFinal Reminder to firm to furnish its reply, failing
	which the case will be	rejected.

of manufacturing** process.||||| |||In view of above, the Committee decided to issueFinal Reminder to firm to furnish its reply, failing|||||| |||which the case will be|rejected.|||||

168	<br>Case No.:169/15/82-<br>ALC4/2018	Party Name:WOCKHARDT<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01626/AM19/	RLA File<br>:03/95/040/00755/AM19/	Lic.No/Date:0310824651<br>24.10.2018	Defer Date:
	Decision:Deferred for comments of TE.

Case No.:424/13/82-	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
ALC4/2018	NITRITE LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044635	Defer Date:
:01/82/050/01402/AM19/	:34/24/040/00144/AM19/	25.10.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 169 Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 :

(i) The Committee considered the case as per agenda and it was observed that the firm vide its e-mail dated 17.12.2019 has furnished a copy of Appendix 4E. However, the same is not readable. Hence, the Committee decided to call for a clear copy of Appendix 4E having complete technical details from the firm through Speed Post.

a copy of Appendix 4E. However, the same is not readable. Hence, the Committee decided to call for a clear copy of Appendix 4E having complete technical details from the firm through Speed Post.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:426/13/82-	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
ALC4/2018	NITRITE LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044636	Defer Date:
:01/82/050/01404/AM19/	:34/24/040/00208/AM19/	25.10.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its 170 Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 :

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

chnical details from the firm through Speed Post.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:453/13/82-	Party Name:HESTER	Meet No/Date:1/82-	Status:
ALC4/2018	BIOSCIENCES LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0810143739	Defer Date:
:01/82/050/01431/AM19/	:08/24/040/00231/AM19/	25.10.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 8/82-ALC4/2019 dated 20.09.2019, followed by Reminder on 26.08.2019 and Final Reminder 171 on 19.03.2020:

(i) Breakup total no. of vials of different doses to be exported. (ii) QA approved batch manufacturing record showing issuance and reconciliation of material for manufacturing vaccine.

172	<br>Case No.:597/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02054/AM19/	RLA File<br>:09/24/040/00345/AM19/	Lic.No/Date:0910066762<br>25.10.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/02054/AM19/|RLA File :09/24/040/00345/AM19/|Lic.No/Date:0910066762 25.10.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

173	<br>Case No.:602/15/82-<br>ALC4/2018	Party Name:GLAND<br>PHARMA LIMITED<br>RLA File<br>:09/24/040/00229/AM19/	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02059/AM19/		Lic.No/Date:0910066775<br>26.10.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

Case No.:603/15/82-	Party	Meet No/Date:1/82-	Status:
ALC4/2018	Name:THERAPIVAPRIVATE	ALC4/2020	Deferred
	LIMITED	17.04.2020
HQ File	RLA File	Lic.No/Date:0910066778	Defer Date:
:01/82/050/02060/AM19/	:09/24/040/00359/AM19/	26.10.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts 174 and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 :

(i) Complete and Balanced Chemical reaction with molecular weight. (ii) Percentage yield on molar basis for each step.

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

i) Percentage yield on molar basis for each step.**

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

	Case No.:605/15/82-	Party Name:SUVEN LIFE	Meet No/Date:1/82-	Status:
	ALC4/2018	SCIENCES LIMITED	ALC4/2020	Deferred
			17.04.2020
175	HQ File	RLA File	Lic.No/Date:0910066781	Defer Date:
	:01/82/050/02062/AM19/	:09/24/040/00354/AM19/	26.10.2018
	Decision:Deferred for comments of TE.

	Case No.:608/15/82-	Party Name:MACSON	Meet No/Date:1/82-	Status:
	ALC4/2018	PRODUCTS	ALC4/2020	Deferred
			17.04.2020
176	HQ File	RLA File	Lic.No/Date:5210042821	Defer Date:
	:01/82/050/02065/AM19/	:52/24/040/00058/AM19/	26.10.2018
	Decision:Deferred for comments of TE.

Case No.:232/13/82-	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
ALC4/2018	NOVOCHEM	ALC4/2020	Deferred
	TECHNOLOGIES LTD	17.04.2020
HQ File	RLA File	Lic.No/Date:3110067218	Defer Date:
:01/82/050/01210/AM19/	:31/83/040/00114/AM19/	29.10.2018

018**||NOVOCHEM||ALC4/2020||Deferred| |||TECHNOLOGIES LTD||17.04.2020||| |HQ File||RLA File||Lic.No/Date:3110067218||Defer Date:| |:01/82/050/01210/AM19/||:31/83/040/00114/AM19/||29.10.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 4/82-ALC4/2019 dated 19.07.2019, 8/82-ALC4/2019 dated 20.09.2019, followed by 177 Reminder on 01.11.2019 and Final Reminder on 19.03.2020.

(i) It has been observed that the chemistry given by the firm is not clear, since the firm has stated that that the raw material shown as phenol while import is of OCP 50. It was decided to ask the firm to furnish exact chemical name of OCP 50 along with manufacturing process and all technical details starting from OCP 50.

The requisite reply is still awaited from the firm. In view of above, the Committee decided to defer the case.

	Case No.:183/13/82-	Party Name:PHAROSE	Meet No/Date:1/82-	Status:
	ALC4/2018	REMEDIES LTD.	ALC4/2020	Deferred
			17.04.2020
178	HQ File	RLA File	Lic.No/Date:3010104485	Defer Date:
	:01/82/050/01161/AM19/	:30/24/040/00032/AM19/	31.10.2018
	Decision:Deferred for comments of TE.

||||17.04.2020||| |178||HQ File||RLA File||Lic.No/Date:3010104485||Defer Date:| |||:01/82/050/01161/AM19/||:30/24/040/00032/AM19/||31.10.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:614/15/82-	Party Name:SUVEN LIFE	Meet No/Date:1/82-	Status:
	ALC4/2018	SCIENCES LIMITED	ALC4/2020	Deferred
			17.04.2020
179	HQ File	RLA File	Lic.No/Date:0910066814	Defer Date:
	:01/82/050/02071/AM19/	:09/24/040/00360/AM19/	08.11.2018
	Decision:Deferred for comments of TE.

180	<br>Case No.:111/15/82-<br>ALC4/2018	Party Name:PUNJAB<br>CHEMICALS AND CROP<br>PROTECTION LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01568/AM19/	RLA File<br>:03/95/040/00709/AM19/	Lic.No/Date:0310824946<br>12.11.2018	Defer Date:
	Decision:Deferred for comments of TE.

181	Case No.:616/15/82-<br>ALC4/2018	Party Name:VIVIMED LIFE<br>SCIENCES PRIVATE<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02073/AM19/	RLA File<br>:09/24/040/00387/AM19/	Lic.No/Date:0910066821<br>12.11.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 09.12.2019 has furnished its reply. Deferred for comments of TE.

r Date:| ||**Decision:**The Committee considered the case as per agenda and it was noted that the firm vide its e-mail dated 09.12.2019 has furnished its reply. Deferred for comments of TE.||||

182	Case No.:87/15/82-ALC4/2018	Party Name:DEEPAK<br>NITRITE LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01544/AM19/	RLA File<br>:34/24/040/00267/AM19/	Lic.No/Date:3410044685<br>13.11.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 02.12.2019 has furnished its reply. Deferred for comments of TE.

Case No.:634/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020
HQ File<br>:01/82/050/02091/AM19/	RLA File<br>:09/24/040/00376/AM19/				Lic.No/Date:0910066832<br>13.11.2018
Decision:The Committee considered the cases as per agenda and in the light of earlier decision taken in<br>meeting<br>no.<br>13/82-ALC4/2019<br>dated<br>31.01.2020, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as<br>applied by the firm, whichever is less:
Export product		Qty.	Sl.<br>No.	Import items		Qty.

020, it was decided to ratify norms under Para 4.7 of HBP v1 as per details given below or as applied by the firm, whichever is less:|||||||| ||Export product||Qty.|Sl. No.|Import items||Qty.|| ||PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM 8:1 FOR INJECTION||1 kg|1|4-Ethyl-2, 3 Dioxo Piperazine (EDP)||0.3323 kg|| |||||2|6-Amino Penicillanic Acid (6- APA)||0.436 kg|| |||||3|Activated Carbon (Carbon Enoanticromos)||0.1783 kg|| |||||4|Isopropyl Alcohol (IPA)||0.050 kg|| |||||5|Methanol (Methyl Alcohol)||0.0009 kg|| |||||6|Methylene Chloride (MDC)||0.105 kg|| |||||7|D(-) Alpha Phenyl Glycine Base (P G Base)||0.335 kg|| |||||8|Penicillin G Amidase (Particle size 250 - 500 micron, Creamish to Brown regularly shaped beads) or (Immobilized Acylase Enzyme) Xinase||2.27 kg|| |||||9|Tazobactam Acid||0.0015 kg|| |||||10|Toluene||0.4384 kg|| |||||11|Triethylamine||0.466 kg|| |||||12|Trimethyl chlorosilane||0.3069 kg|| |||||13|Triphosgene||0.2761 kg|| |||||14|Aluminium Canisters / Bottles with Chloro Butyl Plug / Inner & Outer Lid and Gasket / Alu Caps [21 Ltrs (10Kg Cap)]||Relevant as per packing policy|| ||RA concerned maytake further necessaryaction asper||||above decision of NC.||||

Plug / Inner & Outer Lid and Gasket / Alu Caps [21 Ltrs (10Kg Cap)]||Relevant as per packing policy|| ||RA concerned maytake further necessaryaction asper||||above decision of NC.||||

184	Case No.:623/15/82-<br>ALC4/2018	Party Name:VINS<br>BIOPRODUCTS LTD`	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	HQ File<br>:01/82/050/02080/AM19/	RLA File<br>:09/24/040/00363/AM19/	Lic.No/Date:0910066851<br>14.11.2018	<br>Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 26.03.2020 has furnished its reply. Deferred for comments of TE.

185	<br>Case No.:627/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02084/AM19/	RLA File<br>:09/24/040/00382/AM19/	Lic.No/Date:0910066853<br>15.11.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

186	<br>Case No.:630/15/82-<br>ALC4/2018	Party Name:VIVIN DRUGS<br>& PHARMACEUTICALS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02087/AM19/	RLA File<br>:09/24/040/00391/AM19/	Lic.No/Date:0910066856<br>15.11.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

--|---|---|---|---| || HQ File :01/82/050/02087/AM19/|RLA File :09/24/040/00391/AM19/|Lic.No/Date:0910066856 15.11.2018| Defer Date:| ||**Decision:**Deferred for comments of TE.||||

Case No.:2/15/82-ALC4/2018	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
	NITRITE LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044710	Defer Date:
:01/82/050/01459/AM19/	:34/24/040/00254/AM19/	20.11.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 : 187

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:85/15/82-ALC4/2018	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
	NITRITE LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044711	Defer Date:
:01/82/050/01542/AM19/	:34/24/040/00255/AM19/	20.11.2018

---|---|---| |||NITRITE LIMITED||ALC4/2020||Deferred| |||||17.04.2020||| |HQ File||RLA File||Lic.No/Date:3410044711||Defer Date:| |:01/82/050/01542/AM19/||:34/24/040/00255/AM19/||20.11.2018|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 : 188

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

Case No.:86/15/82-ALC4/2018	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
	NITRITE LIMITED	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044712	Defer Date:
:01/82/050/01543/AM19/	:34/24/040/00256/AM19/	20.11.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 : 189

it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 13/82-ALC4/2019 dated 31.01.2020 , followed by Reminder on 23.03.2020 : 189

In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.

190	<br>Case No.:638/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02095/AM19/	RLA File<br>:09/24/040/00386/AM19/	Lic.No/Date:0910066874<br>20.11.2018	Defer Date:
	Decision:Deferred for comments of TE.

191	<br>Case No.:639/15/82-<br>ALC4/2018<br>Party Name:CADILA<br>HEALTHCARE LTD<br>HQ File<br>:01/82/050/02096/AM19/<br>RLA File<br>:08/24/040/00187/AM19/<br>Decision:Deferred for comments of TE.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:0810143923<br>20.11.2018	Status:<br>Deferred<br>Defer Date:

19/ **Decision:**Deferred for comments of TE.|Meet No/Date:1/82- ALC4/2020 17.04.2020 Lic.No/Date:0810143923 20.11.2018|Status: Deferred Defer Date:| |---|---|---|---|

Case No.:463/13/82-	Party Name:INDIA GLYCOLS	Meet No/Date:1/82-	Status:
ALC4/2018	LTD.,	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:0510408634	Defer Date:
:01/82/050/01441/AM19/	:05/23/040/00359/AM19/	26.11.2018

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 9/82-ALC4/2019 dated 18.10.2019 , followed by Reminder on 09.12.2019 and Final Reminder on 18.03.2020 : 192

(i)	Catalogue of import item No. 2 – Silver Catalyst from the supplier
(ii)	Percentage activity of Silver Catalyst.
(iii)	Recovery / regeneration of Silver Catalyst.
(iv)	Production Consumption Data duly certified by GST/ Chartered
	Engineer.
(v)	Percentage of yield at every stage on molar basis.

The requisite reply is still awaited from the firm. In view of above, the Committee decided to defer the case.

| ||Engineer.| |(v)|Percentage of yield at every stage on molar basis.|

The requisite reply is still awaited from the firm. In view of above, the Committee decided to defer the case.

193	<br>Case No.:649/15/82-<br>ALC4/2018<br>Party Name:GLOBE<br>TROTTERS PVT LTD<br>HQ File<br>:01/82/050/02106/AM19/<br>RLA File<br>:03/94/040/00713/AM19/<br>Decision:Deferred for comments of TE.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:0310825212<br>26.11.2018	Status:<br>Deferred<br>Defer Date:

194	<br>Case No.:659/15/82-<br>ALC4/2018<br>Party Name:AUROBINDO<br>PHARMA LIMITED<br>HQ File<br>:01/82/050/02116/AM19/<br>RLA File<br>:09/24/040/00410/AM19/<br>Decision:Deferred for comments of TE.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:0910066905<br>28.11.2018	Status:<br>Deferred<br>Defer Date:

195	<br>Case No.:664/15/82-<br>ALC4/2018<br>HQ File<br>:01/82/050/02121/<br>AM19/<br>Decision:Deferred	Party Name:<br>SMILAX LABORATORIES<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
		RLA File :09/24/040/00358/AM19/	Lic.No/Date:0910066915<br>28.11.2018	Defer Date:
		for comments of TE.

2- ALC4/2020 17.04.2020|Status: Deferred| |---|---|---|---|---| |||RLA File :09/24/040/00358/AM19/|Lic.No/Date:0910066915 28.11.2018|Defer Date:| |||for comments of TE.|||

196	Case No.:669/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02126/AM19/	RLA File<br>:61/24/040/00012/AM19/	Lic.No/Date:6110001560<br>28.11.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm<br>dated 09.08.2019 has furnished its reply. Deferred for comments of TE.			vide its letter

Decision: The Committee considered the case as per agenda and it was noted that the firm vide its letter dated 09.08.2019 has furnished its reply. Deferred for comments of TE.

197	<br>Case No.:670/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02127/AM19/	RLA File<br>:61/24/040/00013/AM19/	Lic.No/Date:6110001561<br>28.11.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/02127/AM19/|RLA File :61/24/040/00013/AM19/|Lic.No/Date:6110001561 28.11.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

198	<br>Case No.:671/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02128/AM19/	RLA File<br>:61/24/040/00014/AM19/	Lic.No/Date:6110001562<br>28.11.2018	Defer Date:
	Decision:Deferred for comments of TE.

199	<br>Case No.:672/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02129/AM19/	RLA File<br>:61/24/040/00015/AM19/	Lic.No/Date:6110001563<br>28.11.2018	Defer Date:
	Decision:Deferred for comments of TE.

200	<br>Case No.:673/15/82-<br>ALC4/2018	Party Name:VERVE<br>HUMAN CARE<br>LABORATORIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02130/AM19/	RLA File<br>:61/24/040/00018/AM19/	Lic.No/Date:6110001564<br>28.11.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

--|---|---|---|---| || HQ File :01/82/050/02130/AM19/|RLA File :61/24/040/00018/AM19/|Lic.No/Date:6110001564 28.11.2018| Defer Date:| ||**Decision:**Deferred for comments of TE.||||

201	<br>Case No.:674/15/82-<br>ALC4/2018	Party Name:VERVE HUMAN<br>CARE LABORATORIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02131/AM19/	RLA File<br>:61/24/040/00017/AM19/	Lic.No/Date:6110001565<br>28.11.2018	Defer Date:
	Decision:Deferred for comments of TE.


202	Case No.:675/15/82-<br>ALC4/2018	Party Name:VERVE HUMA<br>CARE LABORATORIES	N	Meet No/Date:1/82-<br>ALC4/2020		Status:<br>Deferred
				17.04.2020
	<br>HQ File	RLA File		Lic.No/Date:61100015	66	Defer Date:
	:01/82/050/02132/AM19/	:61/24/040/00016/AM19/		28.11.2018
	Decision:Deferred for comments of TE.

	Case No.:668/15/82-	Party Name:CADILA	Meet No/Date:1/82-	Status:
	ALC4/2018	HEALTHCARE LTD	ALC4/2020	Deferred
			17.04.2020
203	HQ File	RLA File	Lic.No/Date:0810143988	Defer Date:
	:01/82/050/02125/AM19/	:08/24/040/00264/AM19/	29.11.2018
	Decision:Deferred for comments of TE.

||||17.04.2020||| |203||HQ File||RLA File||Lic.No/Date:0810143988||Defer Date:| |||:01/82/050/02125/AM19/||:08/24/040/00264/AM19/||29.11.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:689/15/82-	Party Name:AUROBINDO	Meet No/Date:1/82-	Status:
	ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
			17.04.2020
204	HQ File	RLA File	Lic.No/Date:0910066921	Defer Date:
	:01/82/050/02146/AM19/	:09/24/040/00421/AM19/	29.11.2018
	Decision:Deferred for comments of TE.

	Case No.:684/15/82-<br>	Case No.:684/15/82-<br>	Party Name:GLAND<br>	Meet No/Date:1/82-<br>	Meet No/Date:1/82-<br>	Status:<br>
205	<br>ALC4/2018		PHARMA LIMITED	ALC4/2020<br>17.04.2020		Deferred
	<br>HQ File<br>		RLA File<br>	Lic.No/Date:09100669<br>	30	Defer Date:
	:01/82/050/02141/AM19/		:09/24/040/00419/AM19/	03.12.2018
	Decision:Deferred for comm	ents of TE.

HQ File ||RLA File ||Lic.No/Date:09100669 |30|Defer Date:| ||:01/82/050/02141/AM19/||:09/24/040/00419/AM19/||03.12.2018||| ||**Decision:**Deferred for comm|ents of TE.|||||| |||||||||

	Case No.:685/15/82-<br>	Case No.:685/15/82-<br>	Party Name:GLAND<br>	Meet No/Date:1/82-<br>	Meet No/Date:1/82-<br>	Status:<br>
206	<br>ALC4/2018		PHARMA LIMITED	ALC4/2020<br>17.04.2020		Deferred
	<br>HQ File<br>		RLA File<br>	Lic.No/Date:09100669<br>	31	Defer Date:
	:01/82/050/02142/AM19/		:09/24/040/00420/AM19/	03.12.2018
	Decision:Deferred for comm	ents of TE.

	Case No.:688/15/82-		Party Name:JODAS EXPOIM	Meet No/Date:1/82-		Status:
207	ALC4/2018		PVT.LTD	ALC4/2020<br>17.04.2020		Deferred
	<br>HQ File<br>:01/82/050/02145/AM19/		RLA File<br>:05/23/040/00385/AM19/	Lic.No/Date:0510408748<br>04.12.2018		Defer Date:
	Decision:The Committee considered the case as per agenda and it was observed that the firm was issued<br>Show Cause Notice vide letter dated 10.10.2019.

04.12.2018||Defer Date:| ||**Decision:**The Committee considered the case as per agenda and it was observed that the firm was issued Show Cause Notice vide letter dated 10.10.2019.|||||||

208	<br>Case No.:103/15/82-<br>ALC4/2018	Party Name:STERLING<br>AUXILIARIES PVT LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01560/AM19/	RLA File<br>:03/95/040/00851/AM19/	Lic.No/Date:0310825462<br>05.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

209	<br>Case No.:692/15/82-<br>ALC4/2018	Party Name:ORTIN<br>LABORATORIES LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02149/AM19/	RLA File<br>:09/24/040/00424/AM19/	Lic.No/Date:0910066938<br>05.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

210	<br>Case No.:696/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02153/AM19/	RLA File<br>:09/24/040/00436/AM19/	Lic.No/Date:0910066944<br>05.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/02153/AM19/|RLA File :09/24/040/00436/AM19/|Lic.No/Date:0910066944 05.12.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

211	Case No.:744/15/82-<br>ALC4/2018	Party Name:LUPIN LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Withdrawn
	<br>HQ File<br>:01/82/050/02201/AM19/	RLA File<br>:03/95/040/00876/AM19/	Lic.No/Date:0310825438<br>05.12.2018
	Decision:The firm vide e-mail dated 30.01.2020 has informed that they had applied under para 4.18 of<br>HBP Vol. I and hence they should be exempted from approval of NC.<br>In view of above,the Committee decided towithdrawthe case.

212	Case No.:773/15/82-<br>ALC4/2018	Party Name:LUPIN LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02230/AM19/	RLA File<br>:03/95/040/00902/AM19/	Lic.No/Date:0310825460<br>05.12.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.||||

213	<br>Case No.:466/13/82-<br>ALC4/2018	Party Name:DCM SHRIRAM<br>INDUSTRIES LTD,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01444/AM19/	RLA File<br>:05/23/040/00376/AM19/	Lic.No/Date:0510408809<br>06.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

214	<br>Case No.:698/15/82-<br>ALC4/2018	Party Name:VISION DRUGS<br>PVT LTD	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02155/AM19/	RLA File<br>:09/24/040/00412/AM19/	Lic.No/Date:0910066949<br>06.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

215	<br>Case No.:700/15/82-<br>ALC4/2018	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02157/AM19/	RLA File<br>:03/94/040/00748/AM19/	Lic.No/Date:0310825472<br>06.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/02157/AM19/|RLA File :03/94/040/00748/AM19/|Lic.No/Date:0310825472 06.12.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

216	Case No.:185/15/82-<br>ALC4/2018	Party Name:YASHO<br>INDUSTRIES LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01642/AM19/	RLA File<br>:03/95/040/00925/AM19/	Lic.No/Date:0310825514<br>07.12.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm<br>dated 24.10.2019 has furnished its reply. Deferred for comments of TE.			vide its letter

Decision: The Committee considered the case as per agenda and it was noted that the firm vide its letter dated 24.10.2019 has furnished its reply. Deferred for comments of TE.

217	<br>Case No.:88/15/82-ALC4/2018	Party Name:J.B. CHEMICALS<br>& PHARMACEUTICALS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01545/AM19/	RLA File<br>:03/94/040/00774/AM19/	Lic.No/Date:0310825559<br>10.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

-|---|---|---|---| || HQ File :01/82/050/01545/AM19/|RLA File :03/94/040/00774/AM19/|Lic.No/Date:0310825559 10.12.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

Case No.:715/15/82-<br>ALC4/2018	Party Name:MALLADI<br>DRUGS &<br>PHARMACEUTICALS	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020		Status:<br>Deferred
	LIMITED
<br>HQ File	RLA File	Lic.No/Date:04101649	62	Defer Date:
:01/82/050/02172/AM19/	:04/24/040/00143/AM19/	10.12.2018
Decision:Deferred for comments of TE.

	Case No.:139/15/82-	Case No.:139/15/82-	Party Name:RUBICON	Meet No/Date:1/82-	Meet No/Date:1/82-	Status:
219	<br> <br>ALC4/2018		<br>RESEARCH PRIVATE<br>LIMITED	<br>ALC4/2020<br>17.04.2020		<br>Deferred
	<br>HQ File		RLA File	Lic.No/Date:03108255	87	Defer Date:
	<br>:01/82/050/01596/AM19/		<br>:03/95/040/00889/AM19/	<br>11.12.2018
	Decision:Deferred for comm	ents of TE.

	Case No.:711/15/82-	Party Name:SUVEN LIFE	Meet No/Date:1/82-	Status:
220	<br> <br>ALC4/2018	<br>SCIENCES LIMITED	<br>ALC4/2020<br>17.04.2020<br>Lic.No/Date:0910066959	<br>Deferred
	<br>HQ File	RLA File		Defer Date:
	<br>:01/82/050/02168/AM19/	<br>:09/24/040/00441/AM19/	<br>11.12.2018
	Decision:Deferred for comm	ents of TE.

te:0910066959| Deferred| || HQ File|RLA File||Defer Date:| || :01/82/050/02168/AM19/| :09/24/040/00441/AM19/| 11.12.2018|| ||**Decision:**Deferred for comm|ents of TE.||| ||||||

	Case No.:106/15/82-	Party Name:SONGWON	Meet No/Date:1/82-	Status:
	ALC4/2018	SPECIALTY CHEMICALS	ALC4/2020	Deferred
		INDIA PVT. LTD.	17.04.2020
221	HQ File	RLA File	Lic.No/Date:3410044750	Defer Date:
	:01/82/050/01563/AM19/	:34/24/040/00294/AM19/	12.12.2018
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail
	dated 02.03.2020 has furnished its reply. Deferred for comments of TE.

	Case No.:721/15/82-	Party Name:VERVE HUMAN	Meet No/Date:1/82-	Status:
	ALC4/2018	CARE LABORATORIES	ALC4/2020	Deferred
			17.04.2020
222	HQ File	RLA File	Lic.No/Date:6110001570	Defer Date:
	:01/82/050/02178/AM19/	:61/24/040/00020/AM19/	13.12.2018
	Decision:Deferred for comments of TE.

	Case No.:726/15/82-	Party Name:NATCO PHARMA	Meet No/Date:1/82-	Status:
	ALC4/2018	LIMITED	ALC4/2020	Deferred
			17.04.2020
223	HQ File	RLA File	Lic.No/Date:0910066973	Defer Date:
	:01/82/050/02183/AM19/	:09/24/040/00417/AM19/	18.12.2018
	Decision:Deferred for comments of TE.

7.04.2020||| |223||HQ File||RLA File||Lic.No/Date:0910066973||Defer Date:| |||:01/82/050/02183/AM19/||:09/24/040/00417/AM19/||18.12.2018||| |||**Decision:**Deferred for comments of TE.|||||||

224	<br>Case No.:727/15/82-<br>ALC4/2018	Party Name:AUROBINDO<br>PHARMA LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02184/AM19/	RLA File<br>:09/24/040/00443/AM19/	Lic.No/Date:0910066974<br>18.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

225	<br>Case No.:735/15/82-<br>ALC4/2018	Party Name:CIPLA LIMITED.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02192/AM19/	RLA File<br>:03/94/040/00753/AM19/	Lic.No/Date:0310825758<br>18.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

226	<br>Case No.:736/15/82-<br>ALC4/2018	Party Name:AMI ORGANICS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02193/AM19/	RLA File<br>:52/24/040/00068/AM19/	Lic.No/Date:5210042870<br>18.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

| |---|---|---|---|---| || HQ File :01/82/050/02193/AM19/|RLA File :52/24/040/00068/AM19/|Lic.No/Date:5210042870 18.12.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

227	<br>Case No.:99/15/82-<br>ALC4/2018	Party Name:SUN<br>PHARMACEUTICAL<br>INDUSTRIES LTD.	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01556/AM19/	RLA File<br>:05/24/040/00503/AM19/	Lic.No/Date:0510408988<br>19.12.2018	<br>Defer Date:
	Decision:Deferred for comments of TE.

228	<br>Case No.:738/15/82-<br>ALC4/2018	Party Name:VIVIMED LABS<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02195/AM19/	RLA File<br>:09/24/040/00460/AM19/	Lic.No/Date:0910066983<br>19.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

229	<br>Case No.:1025/15/82-<br>ALC4/2018	Party Name:ANLON<br>HEALTHCARE<br>PRIVATELIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02482/AM19/	RLA File<br>:24/24/040/00044/AM19/	Lic.No/Date:2410042604<br>19.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

-|---|---|---|---| || HQ File :01/82/050/02482/AM19/|RLA File :24/24/040/00044/AM19/|Lic.No/Date:2410042604 19.12.2018|Defer Date:| ||**Decision:**Deferred for comments of TE.||||

Case No.:742/15/82-	Party Name:BEST VALUE	Meet No/Date:1/82-	Status:
ALC4/2018	CHEM PVT. LTD.	ALC4/2020	Deferred
		17.04.2020
HQ File	RLA File	Lic.No/Date:3410044774	Defer Date:
:01/82/050/02199/AM19/	:34/24/040/00295/AM19/	20.12.2018

Decision: The firm vide e-mail dated 29.01.2020 has informed that they had applied for issuance of Advance Authorization under para 4.07 A (self declaration and self ratification) in view of its becoming AEO status holder, but while issuing the subject Advance Authorization, RA inadvertently indicated 230 Advance Licence issued under para 4.7 of HBP 2015-20, for which they have requested RLA,Vadodara to amend the condition sheet of advance authorization to read as Advance Licence issued under para 4.07 A of HBP Vol. I. The Committee considered the request of the firm and it was decided to verify the same from RLA, Vadodara.

RLA, Vadodara vide e-mail dated 23.03.2020 has been requested to verify whether the advance authorization No. 3410044774 dated 20.12.2018 was issued under para 4.07A of HBP Vol. I – Self ratification scheme and whether the firm should be exempted from the approval of NC for the said advance authorization.

3410044774 dated 20.12.2018 was issued under para 4.07A of HBP Vol. I – Self ratification scheme and whether the firm should be exempted from the approval of NC for the said advance authorization.

231	Case No.:743/15/82-<br>ALC4/2018	Party Name:SHUBHLAXMI<br>INDUSTRIES	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02200/AM19/	RLA File<br>:08/24/040/00267/AM19/	Lic.No/Date:0810144119<br>20.12.2018	Defer Date:
	Decision:The Committee noted that the 4.07 application of subject Advance Authorization is not<br>available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization<br>directlyfrom the firm asper PolicyCircular No. 23/2015-20,dated 15.05.2019.

n is not available. Hence, it was decided to call for a copy of 4.07 application of the subject advance authorization directly from the firm as per Policy Circular No. 23/2015-20, dated 15.05.2019.

232	Case No.:748/15/82-<br>ALC4/2018	Party Name:SPANSULES<br>FORMULATIONS	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02205/AM19/	RLA File<br>:09/24/040/00418/AM19/	Lic.No/Date:0910066987<br>20.12.2018	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 03.09.2019 and 28.11.2019 has furnished its reply. Deferred for comments of TE.

233	<br>Case No.:752/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02209/AM19/	RLA File<br>:08/24/040/00303/AM19/	Lic.No/Date:0810144142<br>21.12.2018	Defer Date:
	Decision:Deferred for comments of TE.

	Case No.:925/15/82-	Party Name:OPTRIX	Meet No/Date:1/82-	Status:
	ALC4/2018	LABORATORIES PRIVATE	ALC4/2020	Deferred
		LIMITED	17.04.2020
234	HQ File	RLA File	Lic.No/Date:0910066998	Defer Date:
	:01/82/050/02382/AM19/	:09/24/040/00470/AM19/	24.12.2018
	Decision:Deferred for comments of TE.

ED||17.04.2020||| |234||HQ File||RLA File||Lic.No/Date:0910066998||Defer Date:| |||:01/82/050/02382/AM19/||:09/24/040/00470/AM19/||24.12.2018||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:772/15/82-	Party Name:AUROBINDO	Meet No/Date:1/82-	Status:
	ALC4/2018	PHARMA LIMITED	ALC4/2020	Deferred
			17.04.2020
235	HQ File	RLA File	Lic.No/Date:0910067006	Defer Date:
	:01/82/050/02229/AM19/	:09/24/040/00445/AM19/	31.12.2018
	Decision:Deferred for comments of TE.

	Case No.:775/15/82-	Party Name:SUVEN LIFE	Meet No/Date:1/82-	Status:
	ALC4/2018	SCIENCES LIMITED	ALC4/2020	Deferred
			17.04.2020
236	HQ File	RLA File	Lic.No/Date:0910067014	Defer Date:
	:01/82/050/02232/AM19/	:09/24/040/00482/AM19/	31.12.2018
	Decision:Deferred for comments of TE.

	Case No.:788/15/82-	Party Name:MANKIND	Meet No/Date:1/82-	Status:
	ALC4/2018	PHARMA LTD	ALC4/2020	Deferred
			17.04.2020
237	HQ File	RLA File	Lic.No/Date:0510409149	Defer Date:
	:01/82/050/02245/AM19/	:05/24/040/00552/AM19/	02.01.2019
	Decision:Deferred for comments of TE.

||||17.04.2020||| |237||HQ File||RLA File||Lic.No/Date:0510409149||Defer Date:| |||:01/82/050/02245/AM19/||:05/24/040/00552/AM19/||02.01.2019||| |||**Decision:**Deferred for comments of TE.|||||||

	Case No.:1072/15/82-	Party Name:MALLADI	Meet No/Date:1/82-	Status:
	ALC4/2018	DRUGS &	ALC4/2020	Deferred
		PHARMACEUTICALS	17.04.2020
238		LIMITED
	HQ File	RLA File	Lic.No/Date:0410165065	Defer Date:
	:01/82/050/02529/AM19/	:04/24/040/00218/AM19/	04.01.2019
	Decision:Deferred for comments of TE.

	Case No.:109/15/82-	Party Name:U SQUARE	Meet No/Date:1/82-	Status:
	ALC4/2018	LIFESCIENCE PRIVATE	ALC4/2020	Deferred
		LIMITED	17.04.2020
239	HQ File<br>:01/82/050/01566/AM19/	RLA File<br>:08/24/040/00329/AM19/	Lic.No/Date:0810144243<br>07.01.2019	Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it
	was noted that the firm vide its	e-mail dated 20.03.2020 has furnished its reply. Deferred for comments of
	TE.

Case No.:805/15/82-	Party Name:DEEPAK	Meet No/Date:1/82-	Status:
ALC4/2018	NOVOCHEM	ALC4/2020	Deferred
	TECHNOLOGIES LTD	17.04.2020
HQ File	RLA File	Lic.No/Date:3110067278	Defer Date:
:01/82/050/02262/AM19/	:31/83/040/00157/AM19/	09.01.2019

018**||NOVOCHEM||ALC4/2020||Deferred| |||TECHNOLOGIES LTD||17.04.2020||| |HQ File||RLA File||Lic.No/Date:3110067278||Defer Date:| |:01/82/050/02262/AM19/||:31/83/040/00157/AM19/||09.01.2019|||

Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 9/82-ALC4/2019 dated 18.10.2019 , followed by Reminder on 09.12.2019 and Final 240 Reminder on 18.03.2020 :

(i) Catalogue of OCP. (ii) Certificate of Analysis (CoA) of OCP. (iii) Percentage yield on molar basis.

241	Case No.:123/15/82-<br>ALC4/2018	Party Name:REYAANSH<br>HEALTHCARE	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/01580/AM19/	RLA File<br>:03/95/040/01019/AM19/	Lic.No/Date:0310826282<br>10.01.2019	<br>Defer Date:
	Decision:The Committee considered the case as per agenda in the presence of technical experts and it<br>was noted that the firm vide its e-mail dated 25.03.2020 has furnished its reply. Deferred for comments of<br>TE.

Decision: The Committee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 25.03.2020 has furnished its reply. Deferred for comments of TE.

mmittee considered the case as per agenda in the presence of technical experts and it was noted that the firm vide its e-mail dated 25.03.2020 has furnished its reply. Deferred for comments of TE.

242	Case No.:811/15/82-<br>ALC4/2018	Party Name:ATUL LIMITED,	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02268/AM19/	RLA File<br>:08/24/040/00328/AM19/	Lic.No/Date:0810144290<br>10.01.2019	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 11.11.2019 has furnished its reply. Deferred for comments of TE.

243	Case No.:812/15/82-<br>ALC4/2018	Party Name:BALAJI AMINES<br>LIMITED	Meet No/Date:1/82-<br>ALC4/2020<br>17.04.2020	Status:<br>Deferred
	<br>HQ File<br>:01/82/050/02269/AM19/	RLA File<br>:31/83/040/00158/AM19/	Lic.No/Date:3110067279<br>10.01.2019	Defer Date:
	Decision:The Committee considered the case as per agenda and it was noted that the firm vide its e-mail<br>dated 13.12.2019 has furnished its reply. Deferred for comments of TE.

MANUAL CASES

Case No.	Case No.	Case No.	B- 01	B- 01	B- 01
Meeting No.			1/AM21
Date			17.04.2020
Firm’s Name			M/s Clean Science and Technology Private Limited, Pune
HQ F. No.			01/82/162/00035/AM20/DES-III
Advance Authorization No. and Date			Not issued yet
Subject			Request of M/s Clean Science and Technology Private Limited,<br>Pune for fixation of norms for the export product Ascorbyl<br>Palmitate (ITC HS Code – 29362700) under Para 4.06 of HBP<br>Vol. I (2015-20)
Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>decided to ratify the norms under para 4.06 of HBP Vol. I as per details below:<br>Export Product<br>Qty<br>Sl. No. Import item<br>Qty<br>Ascorbyl Palmitate<br>1 kg<br>1<br>Palmitic Acid<br>0.727 kg<br>2<br>Thionyl Chloride<br>0.470 kg<br>3<br>Ascorbic Acid<br>0.500 kg<br>4<br>N,N Dimethyl Acetamide<br>0.266 kg<br>5<br>Methylene Dichloride<br>1.50 kg<br>RA concerned may take further necessary action as per above decision of NC.
Export Product	Qty	Sl. No.		Import item	Qty
Ascorbyl Palmitate	1 kg	1		Palmitic Acid	0.727 kg
		2		Thionyl Chloride	0.470 kg
		3		Ascorbic Acid	0.500 kg
		4		N,N Dimethyl Acetamide	0.266 kg
		5		Methylene Dichloride	1.50 kg
RA concerned may take further	necessary action			as per above decision of NC.

| ||||3||Ascorbic Acid|0.500 kg| ||||4||N,N Dimethyl Acetamide|0.266 kg| ||||5||Methylene Dichloride|1.50 kg| ||RA concerned may take further|necessary action|||as per above decision of NC.||

Case No.	Case No.	Case No.	B- 02
Meeting No.			1/AM21
Date			17.04.2020
Firm’s Name			M/s Fine Organic Industries Limited, Mumbai
HQ F. No.			01/82/162/00043/AM20/DES-III
RLA F. No.			03/94/040/01001/AM20
Advance Authorization No. and Date			Not issued yet
Subject			Request of M/s Fine Organic Industries Limited, Mumbai for<br>fixation of norms of the export product DATEM (DIACETYL<br>TARTARIC ESTERS OF MONGLYCERIDES) (ITC HS Code<br>– 29161590) under Para 4.06 of HBP Vol. I (2015-20)
Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>decided to ratify the norms under para 4.06 of HBP Vol. I as per details below:<br>Export Product<br>Qty<br>Sl. No. Import item<br>Qty<br>DATEM<br>(DIACETYL<br>TARTARIC<br>ESTERS<br>OF<br>MONGLYCERIDES)<br>1 kg<br>1<br>REFINED HIGH OLEIC SUN FLOWER OIL<br>0.705 kg<br>2<br>Glycerine<br>0.147 kg<br>3<br>TARTARIC ACID<br>0.167 kg<br> RA concerned may take further necessary action as per above decision of NC.
Export Product	Qty	Sl.

N FLOWER OIL 0.705 kg 2 Glycerine 0.147 kg 3 TARTARIC ACID 0.167 kg RA concerned may take further necessary action as per above decision of NC.|||||| ||Export Product|Qty|Sl. No.||Import item|Qty| ||DATEM (DIACETYL TARTARIC ESTERS OF MONGLYCERIDES)| 1 kg|1||REFINED HIGH OLEIC SUN FLOWER OIL|0.705 kg| ||||2||Glycerine|0.147 kg| ||||3||TARTARIC ACID|0.167 kg| ||RA concerned may take further necessary action||||as per above decision of NC.||

Case No.	Case No.	Case No.	B- 03
Meeting No.			1/AM21
Date			17.04.2020
Firm’s Name			M/s Fine Organic Industries Limited, Mumbai
HQ F. No.			01/82/162/00042/AM20/DES-III
RLA F. No.			03/94/040/00931/AM20
Advance Authorization No. and Date			Not issued yet
Subject			Request of M/s Fine Organic Industries Limited, Mumbai for<br>fixation of norms of the export product Monoglyceride (ITC HS<br>Code– 29157030) under Para 4.06 of HBP Vol. I (2015-20)
Decision:The Committee considered the case as per agenda in the presence of technical experts and it was<br>decided to ratify the norms under para 4.06 of HBP Vol. I as per details below:<br>Export Product<br>Qty<br>Sl. No. Import item<br>Qty<br>Monoglyceride - PS<br>1 kg<br>1<br>Hydrogenated Palm Stearin(HPS)<br>0.872 kg<br>2<br>Glycerine<br>0.222 kg<br>RA concerned may take further necessary action as per above decision of NC.
Export Product	Qty	Sl.

1 kg 1 Hydrogenated Palm Stearin(HPS) 0.872 kg 2 Glycerine 0.222 kg RA concerned may take further necessary action as per above decision of NC.|||||| ||Export Product|Qty|Sl. No.||Import item|Qty| ||Monoglyceride - PS|1 kg|1||Hydrogenated Palm Stearin(HPS)|0.872 kg| ||||2||Glycerine|0.222 kg| ||RA concerned may take further|necessary action|||as per above decision of NC.||

Meeting ended with thanks to Chair.

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 7942 --apply.